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DESIGN, FABRICATION, AND VALIDATION OF 3D PRINTED, PATIENT-SPECIFIC
COMPENSATORS FOR POSTMASTECTOMY RADIATION THERAPY

Abstract
Daniel Fowler Craft, B.S.
Advisory Professor: Rebecca M. Howell, Ph.D.

The purpose of this study was to use 3D printed, patient-specific tissue compensators
to overcome the 3D planning limitations for postmastectomy radiation therapy (PMRT).
Tissue compensators can be used to reduce dose heterogeneity, hot and cold spots at field
junctions, and treatment complexity, but are currently seldom used due to the difficulty in
designing, fabricating, and validating them.
To produce compensators using 3D printing technology, suitable materials had to be
found and characterized. Several materials were found to be promising, but previously
unreported material uncertainties were also discovered that must be carefully controlled for
in 3D printing studies. A new algorithm was also created to optimally design the
compensator shape to conform the dose to the desired region, while maintaining acceptable
geometric considerations for 3D printing. Patients’ dose distributions calculated using this
algorithm were superior to dose distributions calculated in those same patients using more
conventional matched field plans. To validate the idealized dose distributions, a new
technique was developed to 3D print patient-specific, large scale radiotherapy phantoms with
dosimeters throughout that can accurately reflect patients’ anatomy better than generalized
phantoms. Six of these phantoms were created for a sample of patients with a range of body
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sizes. A sample of compensators was designed and printed for these novel phantoms, and
radiation doses were measured and compared to planned dose distributions. Measured doses
agreed well with planned doses.
This study demonstrates that 3D printed, patient-specific compensators can be used to
simplify treatments, and improve dose distributions in PMRT patients relative to their
conventional 3D plans. Additionally, the algorithm could be applied to calculate
compensators for different treatment sites in the future, and the phantoms developed could be
used to perform pseudo in vivo dosimetry measurements for a wide range of radiotherapy
experiments.
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Chapter 1: Introduction
Breast cancer is the most commonly diagnosed cancer in women in the United States,
with an expected 266,120 newly diagnosed cases in 20181. Additionally, breast cancer is
second only to lung cancer in cancer fatalities among women, with approximately 41,000
estimated deaths in 2018. One out of eight women in the United States will be diagnosed
with breast cancer in their lifetime1. For node-positive disease, the standard of treatment is
surgical removal of the breast, followed by adjuvant radiation therapy, because this has been
shown to increase the probability of survival, and decrease the risk of loco regional
recurrence2-4.
While postmastectomy radiation therapy (PMRT) has been shown in randomized trials to
improve survival and recurrence outcomes5, it is technically difficult to deliver. The target
region includes the chest wall around the surgical area as well as proximal lymph nodes
(IMC). This is a potentially large area that varies in thickness and composition greatly, with
ribs, fatty tissue, and muscle all in close proximity to each other. The patient’s skin surface is
also likely uneven, with depressions and uneven scarring possible. Another concern is the
relative proximity of important non-target organs, including the heart, lungs, and
contralateral breast, which may all be within a few centimeters of the target. To account for
these difficulties, most PMRT plans use matched tangent photon fields with additional
electron fields for the IMC. While these fields are aligned and matched carefully, these
PMRT plans still result in hot and cold spots at field junctions, are difficult to plan, and are
difficult to set up and deliver6. While intensity modulated radiation therapy (IMRT) is
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occasionally used for PMRT, it is also associated with higher lung, heart, spinal cord, and
contralateral breast doses than conventional 3D plans7.
One option to simplify PMRT treatments is the use of electron therapy in conjunction
with patient-specific tissue compensators. Electrons have a finite range in tissue, so are in
some cases better suited to treating relatively superficial disease sites. When used with a
tissue compensator the dose distribution from an electron beam can be kept quite conformal
around the distal edge of the target area. Techniques to design patient-specific bolus were
first published in the 1990s8, 9. Since then, patient-specific compensators have been used for
PMRT10-12, as well as a variety of other disease sites including cancers of the head and
neck13, 14, basal cell carcinoma15, melanoma16, soft tissue sarcomas17, and other types of
treatment9, 18.
Tissue compensators are not regularly used, despite the advantages they provide in
treatment simplicity and improved dosimetry, due to a combination of inconvenience and
inaccessibility. Compensators conventionally have been fabricated from wax molding and
machine molding, processes that require specialized equipment, are time-consuming and
labor-intensive, and in the case of wax molding are potentially prone to error19. Additionally,
while several techniques have been published describing compensator design8, 13, 20, these
compensator design algorithms are not included as part of most standard treatment planning
systems (TPS).An additional limitation of these compensators is that they are all designed to
fit on a patient’s surface, which requires non-irritating biocompatible materials and is
potentially prone to daily set up uncertainty19.
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One alternative to conventional fabrication is three dimensional (3D) printing technology.
3D printers turn computer designed models into solid objects by depositing single layers of
material down on top of each other. The two most common types of 3D printers are
stereolithography (SLA) printers, which use lasers to cure resin in successive layers, and
fused deposition modeling (FDM) printers, which melt and extrude plastic through a heated
hot-end extruder to trace out each layer21. Layer resolutions can be as small as 15µm for SLA
printers, but are generally limited to 100 µm for FDM printers. However, high quality FDM
printers are much more accessible, and much less expensive (<$15,000) than comparably
sized SLA printers, which can cost in excess of $100,000. There are some design limitations
to what 3D printers can fabricate—for example, as each model grows there must be sufficient
support under layers for the next layer to be deposited on, so extreme overhangs can be
difficult to print—but generally they use less material than other manufacturing techniques,
and can print more shapes with more accuracy and less human involvement. Perhaps most
importantly, FDM printers are relatively simple to use, and can be used to fabricate devices
entirely in-house.
As 3D printers have become more widely available in recent years, interest in using them
for external beam radiotherapy has increased. Within the last several years, Su et al.20 printed
small electron boluses using an in-house design algorithm and an FDM printer, Ju et al.22
printed and evaluated a proton range compensator using an SLA printer, Zou et al.23 printed a
50% scale electron compensator for scalp therapy and a 50% scale proton compensator for
prostate therapy, and Burleson et al.24 printed a small compensator to conform to the nose of
an anthropomorphic phantom. All of these studies used rigid plastics for surface based
devices, and 3D printers with small maximum print volumes (e.g., all print dimensions less
3

than 10 cm). The small maximum print volumes and use of rigid materials for surface based
devices have thus far limited the use of 3D printed compensators to small treatment areas
with rigid anatomy. Another use of 3D printers is the production of patient-specific phantoms
based on patients’ medical images25, 26. Several groups have used 3D printing to make such
phantoms, for a variety of specific applications27-32, but have also been relatively limited by
using smaller-scale printers.
The goal of this study was to use 3D printing technology to overcome limitations in
current 3D treatment planning for PMRT. Specifically, we aimed to characterize 3D printing
materials and processes, develop an algorithm to design 3D printable compensators which
would be positioned at some distance from the patient’s skin surface, evaluate dosimetric
qualities of compensator based plans, and validate compensator planning doses with
measurements in 3D printed, patient-specific phantoms.
Chapter 2 of this dissertation details the hypothesis, specific aims, and various
projects to test each aim. Chapter 3 details our studies into 3D printing material properties.
Chapter 4 describes our fabrication process for 3D printing patient-specific phantoms.
Chapter 5 includes patient dose comparisons as well as phantom validation results. Chapter 6
is a discussion of our results, and future directions of study. The appendices include
supplemental patient data, recommendations on 3D printing settings and procedures, studies
into patient-specific surface based compensators, and the code of the algorithm used and
described in Chapter 5.
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Chapter 2: Central Hypothesis and Specific Aims
Central Hypothesis
The central hypothesis of this dissertation is that 3D printed, patient-specific tissue
compensators can reduce harmful dose inhomogeneity in PMRT patients relative to current
standard of care tangent field plans, while maintaining adequate clinical target coverage.

Specific Aim 1: Characterize 3D Printed Materials and Processes
Aim: Evaluate and optimize 3D printing materials and processes to find suitable plastics for
printing tissue equivalent compensators.
Hypothesis: At least one commercially available material for 3D printing is suitable for use
as a chest wall tissue compensator.
Project 1.1: Print a range of materials, and analyze them for basic physical and
radiological properties such as density, average CT number, print accuracy, etc.
Project 1.2: Perform percent depth dose measurements for a full range of clinical
electron and photon energies for any materials with suitable characteristics.
Project 1.3: Determine clinical reliability of 3D printed materials by printing and
observing several samples over the course of many weeks.
Specific Aim 1 is fully addressed in Chapter 3: Characterization of 3D Printing Materials.

Specific Aim 2: Phantom Development
Aim: Design and fabricate a sample of patient-specific, whole body phantoms of PMRT
patients.
5

Hypothesis: 3D printed phantoms that accurately reflect patient-specific anatomy can be
produced reliably and inexpensively.
Project 2.1: Design and print a selection of full body phantoms based on CT data
from the PMRT patients analyzed in Aim 2.
Project 2.2: Validate printed phantoms with their source CT data.
Specific Aim 2 is fully addressed in Chapter 4: Phantom Development.

Specific Aim 3: Demonstrate Clinical Feasibility
Aim: Create a tool to design patient-specific compensators, and quantify dose distribution
improvements in treatment planning studies relative to patients’ standard of care plans.
Hypothesis: Treatment plans using compensators will satisfy clinical coverage requirements,
while reducing dose inhomogeneity compared to standard treatment plans.
Project 3.1: Develop an algorithm to automatically design patient-specific
compensators that achieve adequate dose coverage.
Project 3.2: For a sample of PMRT patients, apply the compensator design algorithm
and calculate average dose characteristics.
Project 3.3: Compare dose characteristics from project 3.2 with the dose distributions
patients received from their standard of care treatment plans.
Specific Aim 3 is fully addressed in Chapter 5: Design and Validation of Physical
Compensators.
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Specific Aim 4: Validate Compensators with Physical Phantoms
Aim: Validate treatment planning dose distributions using the compensators from Aim 2 and
the phantoms from Aim 3.
Hypothesis: Measured dose distributions in patient-specific phantoms match expected dose
distributions from treatment planning studies.
Project 4.1: Apply the algorithm from Aim 2 to each of the phantoms fabricated in
Aim 3 to design and print a compensator for each phantom.
Project 4.2: Print a wedge compensator and use it to measure dose profiles in solid
water.
Project 4.3: Deliver compensator treatment plans to each phantom, and compare
dose distributions measured with TLD and film with the planned dose distributions.
Specific aim 4 is fully addressed in Chapter 5: Design and Validation of Physical
Compensators.
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Chapter 3: Characterization of 3D Printing Materials
This chapter is based upon the following publication:
D.F. Craft, S. F. Kry, P. Balter, M. Salehpour, W. Woodward, and R.M. Howell, “Material
Matters: Analysis of Density Uncertainty in 3D Printing and its Consequences for Radiation
Oncology,” Medical Physics. Volume 45, Issue 4, pages 1614-1621. 2018. © John Wiley and
Sons, Inc.
The permission for reuse of this material was obtained from the John Wiley and Sons, Inc.
This chapter describes the results of Specific Aim 1: Evaluate and optimize 3D
printing materials and processes to find suitable plastics for printing tissue equivalent
compensators.
I. INTRODUCTION
Within the last several years, 3D printing technology has become an increasingly
utilized tool in the radiotherapy community. The ability to rapidly and accurately
manufacture custom-designed objects has generated much interest in utilizing this technology
to create patient-specific devices and custom in-house phantoms. 3D printers and their
materials are relatively inexpensive and simple to operate, making specialized phantoms and
patient-specific devices a possibility for a fraction of the cost of commercially available
options.
Several recent studies have reported clinical applications of 3D printed objects,
including boluses for the head and neck area33-35, a patient-specific bolus for electron beam
therapy36, and vaginal brachytherapy applicators37. Several studies have examined the

8

potential in the nonclinical setting for customized boluses24, 38, 39 and proton range
compensators23, 40. Another active area of 3D printing research is in creating custom
phantoms used for imaging30, 41, training25, 29, and various radiotherapy applications27, 42, 43.
Despite the great interest in using 3D printed materials for radiologic applications,
relatively little work has been done to fully characterize the radiologic properties of the
materials used for printing. Cunha et al.44 evaluated PC-ISO for use in high dose rate
brachytherapy applicators and found it to be sufficiently water-equivalent for their clinical
workflow. Dancewicz et al.45 and Madamesila et al.31 both characterized materials at
different infill percentages, attempting to match them with various anatomic regions. All of
these studies examined single samples of each material or infill density. While this is an
important reference point, there is inherent uncertainty in the 3D printing process that must
also be accounted for. For example, many of these studies reported different mean
Hounsfield Units (HUs) and physical densities of common materials, suggesting that
different print jobs may, in fact, have different densities. Additionally, these studies have
often failed to address the fact that, for many 3D printing materials, the HU-to-density
relationship cannot be properly modeled by treatment planning systems (TPS) without
overriding material properties24. These findings raise serious concerns about the consistency
and radiologic suitability of 3D printed materials.
In this chapter, we address these issues of consistency and radiologic suitability of 3D
printed materials. Specifically, the objectives of our study were to [1] determine the variance
in HU and density for objects printed with identical equipment and materials, [2] determine if
HU varies over time based on storage environment, and [3] determine the clinical (i.e.,
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dosimetric) dose uncertainty as a function of material variation and how that relates to
clinical use of 3D printed materials.
II. MATERIALS AND METHODS
A. Material Variations
We printed 10 27-cm3 cubes of each of four different materials: polylactic acid
(PLA), acrylonitrile butadiene styrene (ABS), NinjaFlex, and Cheetah. All blocks were
printed by the same Gigabot 3.0 3D printer (re3D, Houston, TX). We selected this printer
because it is a relatively inexpensive (<$15,000), with a large print bed (60 cm × 60 cm × 54
cm) suitable for printing both small and large objects. All blocks of each type of material
were printed from the same original material spool. A computer tomographic (CT) image
was acquired of each block on a Philips Brilliance Big Bore (Philips Healthcare, Andover,
MA) the day after printing, and the physical density of each block was measured using
calipers and a precision balance. Figure 3.1 pictures representative examples of each material
block.

Figure 3.1: Pictures of 3D printed blocks of the four studied materials. From the left: PLA,
NinjaFlex, ABS, and Cheetah.
10

Half of the blocks of each material were stored in an open box and the other half were
stored in sealed bags containing desiccant. Every block was CT imaged once weekly for 5
weeks. For each material and storage type, weekly HU drift trends were plotted and tested for
significance using linear regression analysis.
In addition to the set of blocks printed from the same material spool, we printed a
selection of PLA blocks from different material spools to examine the magnitude of interspool variations. For this test we printed 2 blocks each from 3 different PLA spools from the
same manufacturer as the blocks described above. These blocks were also printed using the
same Gigabot 3.0 printer as the previous blocks. We additionally printed 2 blocks each from
3 different PLA spools from a different manufacturer (MakerBot, New York City, NY).
These blocks were printed using a different printer, the MakerBot Replicator. All of these
blocks’ densities and HU values were recorded, and compared with the standard blocks
described previously.
Printed blocks were also compared to a standard CT calibration curve used to convert
HU values to physical density in our TPS. Differences between predicted block density (from
the TPS calibration curve and the CT images) and actual density (based on physical
measurement) were quantified for each block individually and for each material on average.
The relationships between material HU and density were also tested for significance using
linear regression analysis.
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B. Percent Depth Dose Measurements (Validation)
Because of the observed variation in HU and density of 3D printed blocks, we
determined it was necessary to confirm that dose can be accurately calculated in these
materials when the density is known. To do this we performed percent depth dose (PDD)
measurements and then compared those measurements to TPS calculations made after
overriding the material density. The material density in the TPS was set to that physically
measured for each material tested. These measurements and calculations were performed in
both NinjaFlex and PLA for 6 and 18 MV photon beams as well as 6, 9, 12, 16, and 20 MeV
electron beams.
We printed large blocks of PLA and NinjaFlex, including one 20 cm × 20 cm × 2.5
cm block, two 20 cm × 5 cm × 2.5 cm blocks, a 20 cm × 2.5 cm × 5 mm strip, and a 20 cm ×
2.5 cm × 3 mm strip. Holes were incorporated into the block designs to accommodate the
Exradin A1SL small volume ion chamber (Standard Imaging Inc., Middleton, WI). By
stacking the various blocks in different orders, the ion chamber could be positioned at any
depth from 1 cm to 15 cm at 1 cm increments. By using the 5 mm and 3 mm strips, smaller
measurement increments were possible. The density of each block was also measured.
We performed our measurements using a Varian 2100 linear accelerator (Varian
Medical Systems, Palo Alto, CA). At each measurement point we recorded three
measurements with our ion chamber, and for all measurements the PLA and NinjaFlex
blocks had solid water sheets on either side to ensure scatter equilibrium. All measurements
were done with a 100 cm source-to-surface distance, and all electron measurements were
done using a 10 cm × 10 cm electron applicator.
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The dose at each measurement location was calculated by following the protocol in
the American Association of Physicists in Medicine Task Group 25 report46. Collisional
stopping power ratios were obtained from the NIST program ESTAR47.
We additionally acquired a CT scan of each block configuration and used our TPS,
Pinnacle3 V9.10 (Philips Healthcare), to calculate a PDD for each energy and modality that
we measured using the overwritten density (using the measured density of the printed blocks
of NinjaFlex and PLA, respectively). Finally, the calculated PDD curves (with corrected
densities) were compared with our measured PDD curves.

C. Clinical Implications
The PDD results illustrated that it is possible to accurately calculate dose in 3D
printed materials when their density is known. In general, however, a 3D printed object’s
density is not measured, because such measurement requires additional effort; instead, simple
assumptions are made in clinical practice to make the workflow manageable. Our next step
was to calculate the clinical impact of making a variety of assumptions when the true
material density is unknown.
To quantify the clinical impact, we defined the clinical depth error as the difference in
millimeters between the correct 90% isodose depth (based on the true density) and a 90%
isodose depth calculated when using incorrect (but clinically reasonable) assumptions about
the material properties. Because 3D printed objects could be used in a number of ways, we
decided to calculate this error for two different scenarios: a block of solid material
(configuration 1, representing the printing of a phantom, for example), and a 3-cm block of
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material on top of water (configuration 2, representing 3 cm of bolus placed on top of a
patient).
To determine the error in the clinical depth dose for each clinical assumption, dose
deposition was calculated for each of the four materials in both configurations 1 (solid
material) and 2 (3 cm of material over water) using 6 and 18 MV photons and 6, 9, 12, 16,
and 20 MeV electrons on a Varian 2100. Doses were calculated for a static 10 cm  10 cm
field at 100 cm SSD. The 90% isodose depth for each material and energy was calculated
based on the true density of each material and for each assumed density based on the four
assumptions described below.
The four assumptions considered were based on how these 3D printed materials may
(or have) been used in clinical practice, with each assumption expected to yield greater
accuracy but require additional effort. For each assumption, we determined what density
would be calculated for each material and how much error that density introduced. The
assumptions were: (1) the material is radiologically equivalent to water (i.e., the density of
the material can be set to 1.0 g/cm3 in the TPS); (2) the standard CT calibration curve can
accurately predict the material density based on the CT scan of the material (i.e., CT
scanning the print job and relying on the TPS CT calibration curve); (3) all blocks of a given
material have a density equal to the average material density (i.e., measuring the physical
density of a single print job of a given material and assuming that all other print jobs of that
material have the same density); and (4) after acquiring a CT image, a correction factor can
be applied to the estimated density in order to accurately calculate material density (i.e., CT
scanning the specific print job to get density from the TPS CT calibration curve, and then
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applying a single correction to get closer to the true density based on the average print job of
that material). Each of these assumptions is described in greater detail below.
The first possible assumption is that the material is water equivalent. Anecdotally, we
have seen this assumption made, and it seems an easy simplification to make if a device was
designed in the TPS (e.g., a piece of bolus), printed, and never imaged. For this assumption,
we set the density of the block to 1.0, calculated the 90% isodose depths for each energy, and
calculated the errors as described earlier in this section.
The second possible assumption was that the CT calibration curve accurately predicts
material density, which would be a simple approximation in clinical practice based on CT
imaging of the print job and simply relying on the dose calculation in the TPS. For this
assumption, we input the average HU of each material to the CT calibration curve to
determine the average CT calibration–assumed density plus and minus two standard
deviations for each material. We then calculated the 90% isodose depth for each of those
three densities for each material and energy and under both configurations.
The third assumption was that any object of a given material had the average
measured density of that material. That is, the average density of a sample print job could be
measured carefully once, and that value could be used as the override density in the TPS for
any subsequent print-jobs with that material. To calculate this error, we compared the 90%
isodose depth using the average material density to the 90% isodose depths using the average
density plus two standard deviations and minus two standard deviations.
The final assumption was that the correct material density could be derived by
applying an average correction factor to the CT-estimated density. That is, each individual
print job would be CT scanned to get a print job–specific HU. However, instead of relying on
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the clinical HU-density calibration curve, a scaling factor would be applied based on the
correction factor necessary to map the CT-predicted density to the true density for the
average material. For this scenario, we calculated correction factors for each block, simply
defined as the true density divided by the CT-estimated density. An average correction factor
with accompanying standard deviation was calculated for each material. Next we calculated
the density of each printed block using the CT-predicted density and average correction
factor and then calculated the average error and standard deviation for the predicted density.
These average density errors were used to calculate the 90% isodose depths under this
assumption, which were again compared with the set of true depths to determine the clinical
depth error.

III. RESULTS
A. Material Variations
Of the four materials studied, NinjaFlex had the largest range in measured HU values:
178 HU between the highest and lowest recorded values. PLA was next highest, with a range
of 121 HU. ABS and Cheetah filaments were much lower, both having a range of 30 HU
among their blocks. The range of densities was similarly much larger for both PLA and
NinjaFlex than for ABS and Cheetah. The density ranges for each of the materials are shown
in Figure 3.2.
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Figure 3.2: The spread in measured density values among the 10 blocks of each material.
The solid filled point is the average measured density, and the high and low unfilled points
are the maximum and minimum measured density values, respectively. The error bars around
the average density point show the standard deviation in measured density values.
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Overall, the range in HU drift from week to week was much smaller than the range in
HU values in the original measurements, regardless of storage medium. The average HU drift
of each material and storage type is shown in Figure 3.3. In general, the average HU
decreased for blocks stored with desiccant and increased for blocks stored in open boxes.
However, linear regression analysis on each of these lines identified only two statistically
significant trends: ABS b (P=0.0006) and NinjaFlex b (P=0.002), both stored in open boxes.
Even for these two samples that showed a statistically significant increase in HU as a
function of time, however, the HU changed by only ~15 HU over the full course of 5 weeks.
These changes were small compared to the variation among print jobs, which could exceed
100 HU. As the magnitude of variation is small and is not highly contingent on storage
technique, we decided to focus our error calculations on differences in the original sample,
not on differences caused by drift over time.
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Figure 3.3: The change in average HU relative to its original measured value for each
material in each storage configuration. Average HU drift for materials stored in sealed bags
with desiccant are shown as solid lines, and are labeled as “a” lines. Average HU drift for
materials stored in open boxes are shows as dotted lines are labeled as “b” lines. The only
statistically significant trends were ABS b (P=0.0006) and NinjaFlex b (P=0.002).
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As HU varied between print jobs (Figure 3.2), so too did the measured density of
each block. In general, the density of each material scaled linearly with measured HU (Table
3.1).

Table 3.1: Slope, R2, and P-values from linear regression analysis between HU and density
for each material.
Material

Slope ((g/cm3)/HU)

R-Squared

P-Value

PLA

5.9  10-4

0.96

3.9  10-8

NinjaFlex

7.9  10-4

0.95

1.2  10-6

ABS

4.9  10-4

0.24

0.10

Cheetah

7.6  10-4

0.66

4.4  10-3

This strong correlation between density and measured HU value implies that
variations in HU are due to small variations in the filament size or printing conditions during
printing and not to chemical differences in material that could have happened during printing.
The exception to this finding is ABS. However, ABS also had the smallest recorded range in
both HU values and densities, so this variation is less of a concern in general.
The larger concern with material density and HU is how this relationship compares
with a standard CT calibration curve. Figure 3.4 shows a solid line representing the standard
CT calibration curve used at our institution for the CT scanner used in this study, as well as
data points representing each of the materials we studied. The purpose of a CT calibration
curve is to translate the HU value input from a CT scan to estimate a material density that
will then be used by the TPS. For a material to be accurately modeled by the TPS, it must be
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accurately represented by this curve. Figure 3.4 clearly shows that none of the materials we
studied falls cleanly on this calibration curve. For the CT calibration to accurately predict
density, an average correction factor of 1.058, 1.047, 1.028, or 1.041 is required for PLA,
NinjaFlex, ABS, or Cheetah, respectively.
The PLA blocks printed from different material spools from the same manufacturer
fell within the previously described range, with average HU values of 161, 172, and 187. The
blocks printed on a different printer using PLA were different, with average HU values of 19,
29, and 141. The densities of all of these blocks had correspondingly large ranges, but
followed the linear relationship with HU for PLA shown in Table 3.1.
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Figure 3.4: 3D printed plastics plotted on a standard CT calibration curve. This figure shows
how poorly standard calibration curves model 3D printed material properties. The CT
calibration curve used at our institution for the CT scanner used in this study is shown as the
solid black line. Red squares represent PLA blocks, blue stars represent Cheetah blocks,
purple crosses represent NinjaFlex blocks, and green triangles represent ABS blocks. Note
that, for all materials, the CT calibration curve would underestimate the material density.
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B. Percent Depth Dose Measurements (Validation)
When the density of the PLA blocks was overwritten in the TPS to match the
measured density of the actual blocks used to make the PDD measurements, the calculated
and measured curves matched within 2 mm everywhere and within 1 mm at the 90% depth43.
As can be seen in Figure 3.5a (NinjaFlex) and 3.5b (PLA), we observed similarly good
agreement in NinjaFlex between the measured and calculated PDD curves when we manually
assigned the density in the TPS. Again, the measured and calculated PDDs matched within 2
mm everywhere and within 1 mm at the 90% depth.
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Figure 3.5: Calculated and Measured Percent depth dose (PDD) curves for NinjaFlex and PLA. Density-corrected calculated PDD
curves are shown as solid lines, and our measured points are shown as separate squares. Panel (A) shows NinjaFlex results, and panel
(B) shows PLA results.
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C. Clinical Implications
Table 3.2 shows the range of measured clinical depth errors for the four different
clinical management assumptions considered here, for both solid material and 3-cm slab
configurations, and for the full range of clinical electron and photon energies, in PLA,
NinjaFlex, ABS, and Cheetah.
When assuming that the material was water-equivalent, the overall average error
across energy and material was 4.1 mm. The error was greatest for PLA in an 18 MV photon
beam, reaching a maximum of 9.0 mm. When assuming that the TPS could accurately
calculate the dose based on the CT scan, the average error across all energies and materials
was 1.8 mm. The error was greatest for Cheetah in an 18 MV photon beam, reaching a
maximum of 4.0 mm. When assuming that each print job had the same average material
density, the average error was 1.2 mm. The greatest error was 3.2 mm, which was observed
in NinjaFlex for both 18 MV photons and 20 MeV electrons. When assuming that an average
correction factor can be applied to the CT calibration–predicted density, the average error
was 0.7 mm. The greatest error in this case was 2.7 mm, for NinjaFlex in a 20 MeV electron
beam. As can be seen in Table 3.2, these errors depend strongly on energy and material, but
the general trend holds that assuming a material to be water-equivalent, which is the easiest
assumption in clinical practice, was the worst option; using an average density correction
factor, which is the most involved process in clinical practice (other than physically
measuring the density of every individual print job) was the most accurate option. The
measured errors also tended to be larger for 18 MV than 6 MV and at higher electron
energies.
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Table 3.2: Summary of errors associated with different quality assurance assumptions,
materials, and modalities. All errors are reported in millimeters of 90% isodose line shift.
Assumptions

Material=H2O

Material
Configuration
6 MV
PLA
Ninja
ABS
Cheetah
18 MV
PLA
Ninja
ABS
Cheetah
6 MeV
PLA
Ninja
ABS
Cheetah
9 MeV
PLA
Ninja
ABS
Cheetah
12 MeV PLA
Ninja
ABS
Cheetah
16 MeV PLA
Ninja
ABS
Cheetah
20 MeV PLA
Ninja
ABS
Cheetah

3cm+H2O Solid 3cm+H2O Solid 3cm+H2O Solid 3cm+H2O Solid
3.1
3.1
1.0
2.7
6.5
6.0
0.9
5.7
2.9
2.3
0.7
2.5
4.7
3.9
0.9
3.9
5.9
4.6
0.9
4.8
6.5
5.8
1.1
5.5
6.8
6.2
1.4
5.7

4.7
3.6
1.0
3.8
9.0
6.4
1.4
7.3
2.9
2.3
0.7
2.5
4.7
3.9
0.9
3.9
6.3
4.6
1.4
5.0
7.9
6.0
1.3
6.7
8.4
6.2
1.8
6.9

CT calc is correct

0.9
0.4
1.1
1.1
2.6
1.7
1.6
3.2
0.8
1.4
0.9
0.9
0.9
2.1
1.6
1.6
1.5
1.9
1.6
2.3
1.5
1.4
1.6
2.6
2.1
1.2
2.6
2.8

0.9
1.6
1.1
1.6
3.4
2.8
2.0
4.0
0.8
1.4
0.9
0.9
0.9
2.1
1.3
1.6
1.4
2.5
1.8
2.1
2.3
3.2
2.3
2.8
2.6
3.2
2.9
3.0

Average density

0.6
1.8
0.5
0.3
1.5
3.7
0.7
0.7
0.6
1.4
0.7
0.5
1.0
1.9
0.7
0.3
1.1
1.9
0.4
0.4
1.5
3.0
0.7
0.5
1.3
3.4
1.2
0.7

1.4
1.6
0.7
0.5
2.0
3.2
0.9
1.0
0.6
1.4
0.7
0.5
1.0
1.9
0.7
0.3
1.2
2.3
0.9
0.4
1.4
3.2
1.1
0.7
1.5
3.2
1.4
0.7

Use average corr.

0.2
1.4
0.5
0.3
0.5
1.8
0.5
0.6
0.2
0.4
0.5
0.3
0.4
0.7
0.3
0.3
0.7
0.9
0.5
0.5
0.7
2.0
0.2
0.5
0.7
2.7
0.7
0.7

0.8
0.5
0.7
0.3
0.8
1.4
0.7
1.2
0.2
0.4
0.5
0.3
0.4
0.7
0.3
0.3
0.6
0.9
0.5
0.2
0.6
1.1
0.5
0.7
0.5
1.6
0.7
0.7
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To further illustrate the potential error in assuming a material is water-equivalent,
Figure 3.6 shows our measured PDD curves in NinjaFlex and PLA compared to the standard
water PDD curves used in commissioning this linear accelerator. For those particular blocks,
the water curves severely overestimate dose in PLA and underestimate dose in NinjaFlex.
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Figure 3.6: Percent depth dose curves for NinjaFlex, PLA, and water. This figure demonstrates how poor of an assumption it is to
make that either NinjaFlex or PLA are radiologically water equivalent. Measured NinjaFlex points are shown as squares, measured
PLA points as triangles, and standard water PDD curves as solid lines. 6, 9, 12, and 16 MeV PDD curves are shown because they are
representative of the full set of measured energies.
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IV. DISCUSSION
In this chapter, we examined the HU and density uncertainties of 3D printed
materials, between blocks printed from the same material rolls and on the same 3D printer,
and calculated the effect this uncertainty has in determining the depth of the 90% isodose line
at a full range of clinical photon and electron energies. We have shown that printing a single
block of a material is not sufficient to determine if a material can be used for radiation
therapy applications, but that 3D printing materials can be safely used if proper steps are
taken to correctly model them in the TPS.
Our first interesting finding was that widely used materials such as PLA and
NinjaFlex have large spreads in HU and density, even when printed from the same material
roll and on the same 3D printer. While the spreads for the other materials we examined (ABS
and Cheetah) were not nearly as large, there was variation there as well. We have also shown
that density variations between filament spools are similar when using the same printer and
manufacturer, but can be quite different for a different printer and manufacturer. It is an
important point that many factors can affect HU and density. Using a different printer, using
filament from a different manufacturer, or even different rolls of the same filament from the
same manufacturer, can all strongly affect the properties of printed objects. This indicates
that every 3D printed object may require individual characterization; characterizing a
material once does not guarantee that its properties will be the same in subsequent print jobs.
Despite this large range in initially measured HU values, the blocks were much more
stable over time after printing, with a maximum change of 16 HU (compared with a
minimum initial range of 30 HU and maximum of 178 HU). Also interesting was that the HU
drift over time was not strongly dependent on storage environment. These two findings lead
us to believe that, after initial characterization of the printed objects, the properties of 3D
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printing materials do not change substantially and no special storage conditions are
necessary. To be entirely safe, an object that has not been used for several months may
require reexamination before being used again.
The most important findings in our study relate to the various potential quality
assurance steps that need to be taken to adequately characterize a 3D printed object. In Figure
3.5 (also see Chapter 4), we have shown that 3D printed materials can be accurately modeled
by the TPS provided that the correct material density is known and used. It is important to
note that, in the 3D printing setting, a material’s HU value alone is not sufficient to achieve
accurate dose calculation accuracy, because the relationship between HU and density does
not follow the traditional CT calibration curve. Table 3.2 and Figure 3.6 show that, when
material density is not correctly assigned, potentially large errors can occur. Depending on
the needs of an individual clinic, some of our measured errors may be acceptable. At a
minimum, however, it should not be considered acceptable to assume that 3D printed
materials are water-equivalent, or that the TPS will accurately manage these materials using
clinical CT calibration curves. For optimal results, every 3D printed object should be CTimaged and have its physical density measured. We do not believe this is an overly large
burden because, in designing a 3D printable object, the exact designed volume will be
known, and even complex 3D printed objects print with very small volumetric errors23, 43.
Precise scales are also relatively inexpensive. By knowing the density and CT information
for each object, this source of potential error can be effectively eliminated.
Another advantage of acquiring a CT image of every object is that it allows a review
of the density and HU homogeneity throughout the printed object. Severe internal errors are
not a common finding; Zou et al.23 found these internal block variations accounted for a shift
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of the 90% isodose of less than 1 mm. Nevertheless, such a step provides an additional layer
of quality assurance and may be particularly important when implementing a new material or
printing technique into a 3D printing workflow.
A limitation of this study is that we considered only four of the many materials that
can and have been used for these applications. Additionally, the precise error measurements
that we made are only truly applicable to our printing workflow and machines. A different
TPS, CT scanner, or 3D printer may change these results. However, we believe that the
general magnitude of error, and especially the ranking of errors, will likely remain stable
across platforms. For example, if another clinic finds its errors are larger when assuming a
material is water-equivalent than what we have presented here, the best choice is still to
measure and manually assign its density in the TPS. Nonetheless, this chapter provides
guidance for evaluating materials for radiotherapy applications and the overall clinical effect
of various assumptions in the treatment planning process.

V. CONCLUSIONS
Our results show that a variety of 3D printed materials can be used safely to create
patient-specific phantoms or radiotherapy devices under certain conditions. Specifically, each
material and print process must be carefully characterized for both the spread in HU values
and densities. We found that when poor assumptions are made about 3D printed materials,
errors in the 90% isodose position could be as large as 1 cm. Assumptions that should be
avoided are that 3D printed materials are water-equivalent, or that the clinical CT calibration
curve can accurately determine the density of 3D printed materials. When correct steps were
taken to account for these plastics’ special relationship of density to HU, 90% isodose
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position errors were generally less than 1 mm. In conclusion, 3D printing technology can be
extremely useful in creating innovative research and clinical tools in radiotherapy, but care
needs to be taken to ensure that dose calculations involving these devices are accurate.
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Chapter 4: Phantom Development
This chapter is based upon the following publication, with additional material provided to
detail multiple phantoms being printed:
D.F. Craft and R.M. Howell, “Preparation and fabrication of a full-scale, sagittal-sliced, 3Dprinted, patient-specific radiotherapy phantom,” Journal of Applied Clinical Medical Physics.
Volume 18, issue 5, pages 285-292. 2017. © The Authors.
The permission for reuse of this material was obtained from the authors.
This chapter describes the results of Specific Aim 2: Design and fabricate a sample of
patient-specific, whole body phantoms of PMRT patients.
I. INTRODUCTION
In radiation therapy, commercially available anthropomorphic phantoms can be used
for end-to-end quality assurance (QA) of new treatment techniques. Such phantoms are
generally available in only four forms: male, female, child, and infant. These phantoms have
average body mass indices, but most patients’ individual anatomy differs greatly from that of
the representative phantoms. For example, a post-mastectomy woman with a high body mass
index is not accurately represented by the standard adult female phantom. A patient-specific
phantom that accurately represents an individual’s specific anatomy has greater validity than
the standard phantom as a model in a variety of research and clinical applications. Patientspecific phantoms have many potential uses in radiotherapy but are generally not
commercially available. This lack can be attributed to the development time and expense
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required to individualize the production process. Three-dimensional (3D) printing is one tool
that potentially can be used to inexpensively custom-fabricate patient-specific phantoms.
Several studies published in recent years have shown the advantages of 3D printed
phantoms for use in radiotherapy and in other areas of medicine. Ehler et al.27 printed a shell
of a generalized head and filled it with wax to be used for intensity-modulated radiation
therapy QA. Ger et al.48 also printed a shell of a head, but filled it with variable-density
materials to make a heterogeneous head phantom. Similarly, Gear et al.28 printed liquidfillable shells, but of patient-specific organs, to be used as molecular imaging phantoms.
Nattagh et al.29 created a training phantom for ultrasound-guided needle insertion and
suturing during gynecologic brachytherapy procedures. As proposed by Burleson et al.24, 3D
printed exterior molds of a patient can be useful as a way to fit electron bolus before
treatment for patients with open wounds or sensitive skin. 3D printed patient-specific
phantoms have also been found to be helpful in surgical planning49 and in the education of
medical residents for surgeries of the liver50 and brain51. In general, patient-specific
phantoms could be used not only for end-to-end QA of new radiation therapy techniques but
also to perform QA for routine treatments on patients with highly atypical anatomy25.
Despite the conceptual simplicity of 3D printed patient-specific phantoms, they have
several key limitations. Two of these are the small size of most commercially available 3D
printers23 and the tendency of printed objects to warp or become distorted while printing24.
Warping happens because of the way objects are printed in successive layers. Different layers
cool and contract at different rates, causing the object being printed to curl upward from the
build platform as layers separate from each other. In severe cases, the warping object can
impede the path of the extruder and cause the model to stop printing. In other cases, this
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warping is minor, affecting only the bottom few layers. The warping effect is heightened
when large surfaces of the object being printed are in contact with the print bed. Warping is
also much more problematic when an object is being printed at 100% infill (solid) rather than
at a lower infill percentage or as a hollow shell. Warping is most prevalent with 3D printers
that use fused deposition modeling technology, but other printing technologies, like
stereolithography, are generally even more limited in total print volumes making them
impossible to use for large phantoms.
Many of the published studies have minimized the impact of warping by printing only
a shell of the phantom and then filling it with water or wax. These liquid-filled phantoms are
more complicated to design, however, and are homogenous without internal air gaps.
Additionally, all of the reported studies of 3D-printed phantoms are for small anatomical
regions (i.e., head or smaller), where the impact of warping is minimal. The goal of this
chapter was to develop and test a 3D printing workflow with minimal warping error that can
be used to print any large anatomical region with 100% infill representing tissue, while
allowing for inclusion of low-density air-filled regions. Then, using that workflow we aimed
to design and print a set of six full-sized patient-specific phantoms based on PMRT patients.
Throughout this chapter we will detail the steps taken to print the first phantom, then
summarize the results of all six.

II. MATERIALS AND METHODS
We printed the first phantom as eleven 2.5-cm-thick sagittal slices, with the inferior
aspect of each slice in contact with the print bed. This approach was chosen with the goal of
minimizing the extent and effects of material warping on our phantom. 3D printed objects
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warp primarily from their contact with the print bed, so orienting all the slices in the sagittal
plane accomplishes two things. First, only 2.5 cm of the slices make contact with the print
bed, rather than the entire width of the phantom, so there is less overall surface area to warp.
Second, because any warping that does occur is localized to the inferior aspect of the slice, it
doesn’t obstruct the contact points between slices. The superiority of sagittal slices over axial
slices in respect to warping is illustrated in Figure 4.1.
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Figure 4.1. Slice orientation and material warping. This is a representation of what a square
phantom might look like if printed in different orientations. (a) and (b) show how warping
could affect slices printed in the axial and sagittal planes, respectively, due to the edges
curling up from the print bed. All parts are shown as if they were printed with their inferior
aspect in contact with the print bed. Note that in (b) there is overall less warping from the
desired square, and the warping that does happen doesn’t affect the contact between slices.
(c) is a picture of a 3D printed block with warping observed on the edges that were in contact
with the printing bed during printing.
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A. 3D Printing File Preparation
We designed our first printed phantom directly from a computed tomography (CT)
image of a 76-year-old woman who had undergone a left-sided mastectomy. This patient
(and all others for whom we printed phantoms) is part of an Institutional Review Board–
approved cohort of patients for retrospective studies. The first step in developing ready-toprint files was to export the patient-of-interest’s DICOM data from the clinical planning
system, Pinnacle3 (Philips Healthcare; Andover, MA), to the DICOM imaging software
OsiriX (Pixmeo; Bernex, Switzerland). The sequence of steps is diagramed in Figure 4.2.

Figure 4.2. Workflow diagram showing the steps and software used to prepare files for 3D
printing, from treatment planning (TPS) to product.
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Using OsiriX’s voxel value reassignment function, we set the Hounsfield unit (HU)
value of voxels outside the area of interest to -1024. This effectively cropped those areas
from the final 3D skin rendering. We cropped the arms to simplify printing and the head to
preserve patient anonymity. Once the CT image was processed within OsiriX, we used the
3D surface rendering function to produce a 3D model of the image for all voxels with an HU
above a threshold of -500. That threshold value keeps all soft tissue and bone as one material,
but leaves open air cavities such as the trachea and lungs. This whole-body model was then
exported to the 3D model manipulation software netfabb (netfabb GmbH; Parsberg,
Germany), now Autodesk (San Rafael, CA).
Netfabb has a special cutting function that we used to slice the original whole-body
model into 2.5-cm-thick sagittal slices. Each individual slice was then exported into
MeshLab, another 3D model manipulation program. This open source and free to use system
developed by the 3D-CoForm project allows piece-by-piece editing and cropping. In
MeshLab, each slice was examined for any overhanging or free-hanging parts that would
cause printing errors. For example, sagittal slices that intersect the lungs often left parts of
the bronchi unsupported, so those parts were deleted. These sections were generally small.
Once every slice was cleared of overhanging parts, they were transferred to Simplify3D
(Simplify3D; Cincinnati, OH). This software translates 3D models into g code, the language
used by our 3D printer to define print jobs. Each slice was oriented with its flat 2.5-cm-thick
inferior aspect on the print bed. The print-ready files were saved onto an SD card.
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B. Phantom Fabrication
All slices were printed by a Gigabot 2.0 printer (re:3D; Houston, TX). The Gigabot
has the capacity to print objects with dimensions up to 60 cm × 60 cm × 54 cm (x, y, z) with
a layer resolution of 100–300 microns and x-y resolution of 4 microns. This build volume is
much larger than those used in previous studies27, 28, 31. Each slice was printed with a 300micron layer resolution at 100% infill using 2.85 mm polylactic acid (PLA) filament (re:3D;
Houston, TX). Many different materials’ radiological properties have been studied, but the
two most widely used are PLA and acrylonitrile butadiene styrene (ABS). Both materials are
nearly identical in price and printing speed, and both have similar radiological properties to
water23, 24, 27, 52. However, ABS warps considerably more than PLA which makes it extremely
difficult to use for large objects printed at solid infill24, 53. PLA was chosen primarily for its
superior warping characteristics, and the fact that we have previously shown in Chapter 3
that we can accurately model it in our TPS.
The settings used by the printer can strongly affect the degree of warping observed,
so each of the settings used by this experiment were informed based on previous experience.
Many objects were printed with solid infill using various settings, and the settings below
were found to be the best practice for minimizing warping and limiting print failures. The
printing bed was set to 60°C and the print nozzle to 225°C. The extrusion multiplier, or flow
rate, was set to 90%, and the nozzle’s print speed was 60 mm/sec. The printing bed is made
of BuildTak (Ideal Jacobs Corporation, Maplewood, NJ), but unlike many other experiments
with 3D printing, no other tape or adhesive was applied to the bed. As each slice was printed,
we recorded the total time to print it, the mass of the material used, and the total cost of the
material. Average slice and total phantom printing parameters were then calculated. After the
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3D printing was completed, we drilled two holes across each slice so that plastic
immobilization rods could be placed to hold the phantom slices together. We additionally
drilled 17 holes for TLD to be placed throughout the phantom: 9 in the chest wall, 3 in the
heart, and 5 in the intact right breast. For the subsequent phantoms 2-6 these immobilization
rod holes and TLD holes were incorporated into the initial design and did not need to be
drilled after printing.

C. Material Analysis
To determine the attenuation properties of the PLA material used for the phantom, we
printed several 5 cm × 5 cm × 5 cm cubes of PLA. The cubes were imaged on a Phillips
Brilliance Big Bore CT scanner (Philips Healthcare, Andover, Massachusetts). The CT
number of each block was recorded, and the blocks were weighed and measured to determine
their volume, density, and print accuracy. Percent depth doses measurements were also
performed on PLA as reported earlier in Chapter 3.

D. Phantom Verification
We evaluated the first phantom’s slices both individually and collectively. Before
drilling the holes for the placement of the immobilization rods, a CT scan was acquired of
each individual slice on a Philips Brilliance Big Bore (Philips Healthcare; Andover, MA).
We also measured the thickness of each slice at its superior, anterior, and inferior aspects
with sub-millimeter resolution calipers. We defined the per-slice printing accuracy in two
ways: measured accuracy and volumetric accuracy. The measured accuracy was defined by
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calculating the average discrepancy between the measured and planned thicknesses at the
top, middle, and bottom of each slice. The volumetric accuracy of each phantom slice was
defined by comparing the volume of the 3D rendering of the CT scan with the model created
for printing.
After the rods were placed, we acquired a CT scan of the entire phantom. The
assembled phantom accuracy was evaluated by registering its CT image with the original
patient CT image and examining the slice-by-slice alignment in all three planes.
Additionally, average CT numbers were measured throughout the phantom and patient
images to determine the CT number discrepancy in various anatomic regions.

III. RESULTS
A. 3D Printing File Preparation
Preparing the eleven slices from the original CT data was straightforward and simple.
The process of cropping the CT scan, converting it to a 3D model, and slicing it into 2.5-cm
slices took less than 30 minutes once we were familiar with the workflow. Preparing each
individual slice for printing took slightly longer, approximately 10 minutes per slice, or 2
hours in total. In total, preparing all 6 phantoms took approximately 12 hours of work.
B. Phantom Fabrication
Each slice printed correctly on its first attempt with the same settings. Pictures of the
first printed phantom before and after the immobilization rods were placed are shown in
Figure 4.3. The slices fit together well, and a high degree of detail was preserved. Figure 4.4
shows all the printed phantoms.
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Figure 4.3: Photographs of a 3D printed phantom. (a) and (b) show the entire phantom
before and after placement of immobilization rods, respectively. Note that gaps between
slices were significantly reduced with the application of the immobilization rods. (c) shows a
view of the phantom with the two left-most slices removed, and (d) shows an individual
slice.
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Figure 4.4: Photographs of the set of 6 3D printed PMRT phantoms. Panels (a) and (b) are
from patients with BMI category 2 (normal weight), panels (c) and (d) are from patients with
BMI category 3 (overweight), and panels (e) and (f) are from patients with BMI category 4
(obese).
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The time to print each slice, the mass of each slice, and the cost of each slice are
reported in Table 4.1. In total, the first phantom took 267.5 hours to print, weighed 12.53 kg,
and cost $524 in raw materials. Table 4.2 summarizes these statistics for all 6 phantoms that
we printed.
Table 4.1: Print statistics for each individual slice, average, and total.
Slice
Print Time (hr:min)
Mass (g)
Cost (US dollars)
1

31:41

1520.85

63.57

2

19:24

899.63

37.60

3

16:42

767.35

32.08

4

19:19

884.90

36.99

5

30:56

1446.55

60.47

6

35:14

1666.45

69.66

7

27:23

1267.11

52.97

8

19:48

913.50

38.18

9

17:28

801.73

33.51

10

22:28

1061.45

44.37

11

27:07

1296.15

54.18

Average

24:19

1138.70

47.60

Total

267:30

12,525.67

523.58
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Table 4.2: Individual, average, and aggregate print statistics for each phantom.
Phantom
BMI
Print Time
Slices
Mass (kg)

Cost (US

Category

(hr:min)

1

2

267:30

11

12.53

523.58

2

2

284:59

11

12.97

542.28

3

3

346:22

12

15.88

663.62

4

3

339:00

13

15.39

643.52

5

4

410:37

13

18.81

786.11

6

4

415:37

13

19.00

794.33

Average

3

344:00

12.17

15.73

658.91

NA

2064:05

73

94.58

3953.44

Total

dollars)

C. Material Analysis
We found that the printed PLA blocks had a mean HU of 160±12, a physical density
of 1.20 relative to water, and print errors of 1.09 mm on average.
The treatment planning system calculated PDDs and the measured PDDs agreed
within 2 mm for all electron energies. The 6 and 18 MV photon beams measurements and
calculations agreed within 2% Figure 3.5).
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D. Phantom Verification
The measured slice errors were all positive, meaning the slices were consistently
larger than planned, and ranged from 0.44 mm-0.60 mm, with an average of 0.52 mm across
all eleven slices. The average error at the bottom of the slices was 0.76 mm, while the errors
at the middle and top were 0.51 mm and 0.29 mm, respectively. The decreasing error as the
slice gets further from the print bed is consistent with previous observations that more
warping occurs at the contact point between the printing surface and the object being printed.
The volumetric errors of the individual slices ranged from 0.75%–1.83%, with an average
across all slices of 1.37%. The slices printed relatively homogenously, and had a mean HU of
155 with a standard deviation of 18. Figure 4.5 shows an image of one slice as it was planned
and as it was imaged.
There was excellent agreement between the original patient CT scan and the
assembled phantom CT scan for all 6 phantoms. Figure 4.6 shows slices of each CT scan
next to each other for phantom 1, as well as the 3D model of the imaged phantom and
original patient. The only disagreement between the phantom and patient data sets was in the
lungs, where unsupported nodules were cropped to make printing possible (see section II.A).
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Figure 4.5: 3D-rendered models of slice number 1.8. (a) is the planning model used to print
slice 8, and (b) is the model based on the CT scan of the actual printed slice. Figure 3(d) is a
photograph of this same slice.
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Figure 4.6: Comparison of the original patient CT scan registered with the completed
phantom CT scan. Panels on the left show slices of the original patient CT scan, panels in the
middle are from the CT scan of the assembled phantom, and panels on the right are the 3D
rendered models of the original patient and the phantom. (a) and (b) compare axial slices, (c)
and (d) compare coronal slices, and (e) and (f) compare sagittal slices. (g) and (h) compare
rendered models of the phantom and patient CT scans, respectively.
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The average CT numbers of the patient 1 and printed phantom 1 are reported in Table
4.3. In general, the printed phantom had a CT number around 140 HU higher than the
patient’s soft tissue, but is 100 HU lower than the patient’s spinal area. The lungs of the
phantom were also 130 HU lower than in the patient.

Table 4.3: CT number measurements for patient 1 and phantom 1 images.
Phantom CT
Patient CT
CT Number
Location

Number (HU)

Number (HU)

Discrepancy (HU)

Heart

133±77

25±25

108

Breast

82±145

-61±47

143

Arm

133±90

-5±95

138

Left lung

-989±8

-862±90

-128

Right lung

-993±7

-861±95

-132

Spine

132±65

227±164

-95

IV. DISCUSSION
In this chapter, we successfully produced 6 patient-specific, 3D printed phantoms
using a commercial printer and readily available software and materials. All software used in
the design and preparation of print files was acquired or licensed for under $1000. The
phantoms were printed in sagittal sections to minimize the impact of material warping.
Although the overall phantoms were large (35 cm × 25 cm × 32 cm), they had minimal
warping (<2%). Because the small amount of warping observed was primarily in the inferior
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portion of the phantoms (closest to the print bed during printing), the individual slices were
well aligned in the fully assembled phantom. Accurate, simple, and inexpensive phantoms
like these could be valuable for a variety of radiotherapy applications in both research and
clinical settings. These particular phantoms have been useful to us as a tool in developing
breast compensators that can fit on irregular patient anatomy (see Chapter 5). Standard
anthropomorphic phantoms are not designed to mimic patient treatment positioning, e.g.,
breast patients are simulated with their ipsilateral arm raised above the head. This type of
patient specific phantom can be highly useful and informative in scenarios such as our
present work designing patient-specific compensators for breast cancer and many other
treatment sites or patient-specific QA of treatments where patients are in atypical treatment
positions.
Our printed phantoms differs from those described in other published work in several
ways. Because of material warping, most 3D printed phantoms in the literature have been
printed as a shell and then filled with liquid to make them solid27-29. Our phantoms were
printed at 100% infill, which reduces the amount of work involved in the overall fabrication
process. Concerns about material warping have also limited the size of most phantoms, as has
the scarcity of large-scale 3D printers. By printing slices in the sagittal orientation on the
recently available Gigabot 2.0, we were able to create large (up to 2.5 cm × 23 cm × 32 cm)
solid parts while still keeping warping errors under 2%.
One of the greatest advantages of our printed phantom is its relative cost. Including
software, hardware, and materials, fabricating our first phantom cost less than $15,000, and
additional phantoms cost on average $660 in materials. Traditionally manufactured standard
anthropomorphic phantoms can cost more than $20,000, while patient-specific ones cost
51

much more. Related to cost is the simplicity of our process. The fabrication process and steps
outlined in this study can be used on demand to rapidly design and produce not only fullsized phantoms, but any patient-specific model of any size.
The limitation of the phantom is that both soft tissue and bone were represented by
PLA. While the radiological properties of PLA are between those of bone and water, PLA is
not a perfect approximation for either. The addition of a second material to simulate bone and
give the phantoms some heterogeneity would potentially be advantageous. Some groups have
reported work on variable-density 3D printed phantoms, and while their work is promising,
the variable density either has a high dependence on the direction of radiation31 or requires a
complicated custom extrusion system and labor-intensive post-processing work48. Recently,
we acquired a new Gigabot 3D printer with an additional extruder with the capacity to print
with multiple materials. Future work will include the addition of multiple-material printing to
the workflow described here.
It is an important point to reiterate that PLA is not dosimetrically identical to water.
Further, complex printed objects tend to have a lower HU than simple blocks, with an
electron compensator having 107 HU compared to its 130 HU block23, and our own phantom
having a mean HU of 133, compared to our 160 HU blocks. Additionally, PLA does not fall
on a standard CT calibration curve due to its density of 1.20 relative to water. In order to
accurately calculate dose in PLA the HU or physical density must be manually overwritten.
Burleson et al. found they could accurately calculate PDDs in PLA if they set the HU to
26024, and in our own PLA PDD measurements we similarly measured the density and set it
to 1.20 g/cm3 in order to get accurate calculations (see Chapter 3). In summary, the physical
and radiological properties of PLA have been characterized and we have demonstrated that it
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can be used to fabricate patient-specific single material radiation therapy phantoms. While
implementation of multi-material 3D printed phantoms would be a further improvement,
homogeneous phantoms are at present routinely used for many types of radiation treatment
QA. Examples include patient-specific IMRT QA and accreditation procedures for clinical
trials54, 55.
Another limitation was the time required to print the phantom. While preparation was
straightforward and not very time-consuming, printing the entire first phantom took over 11
days and positioning rods and TLD holes had to be manually drilled. Subsequently, for
phantoms 2-6 the positioning rod and TLD holes were designed into the original slices,
reducing the need for post-printing manual labor. However, the full time to print all 6
phantoms was approximately 94 days. Because of this long print time, large patient-specific
phantoms are not currently feasible for routine patient-specific QA procedures. With a welldefined workflow, however, in-house fabricated 3D printed phantoms can be an inexpensive,
simple, and accurate alternative to commercially available phantoms and can be used to
perform end-to-end QA of new radiation therapy techniques and for various research
applications.

V. CONCLUSION
This chapter has shown that large patient-specific phantoms can be fabricated with
high accuracy on inexpensive, commercially available 3D printers. We successfully used real
patient data to make six anatomically accurate, full-scale phantoms, overcoming previously
encountered 3D printing limitations of size and material warping. Our method required no
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customized software or materials and was simple to execute. With multiple-material
extrusion printers, patient-specific phantoms could be improved further and could soon be a
viable tool for many research and clinical tasks.
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Chapter 5: Design and Validation of Physical Compensators
This chapter is based on the following manuscript, which has been submitted to Radiotherapy
and Oncology, and is currently under review:
D.F. Craft, P. Balter, W. Woodward, S. F. Kry, M. Salehpour, R. Ger, M. Peters, G. Baltz, E.
Traneus, and R.M. Howell, “Design, Fabrication, and Validation of patient-specific tissue
compensators for postmastectomy radiation therapy,” In review. (2018).
This chapter describes the results of Specific Aim 3: Create a tool to design patientspecific compensators, and quantify dose distribution improvements in treatment planning
studies relative to patients’ standard of care plans, and describes the results of Specific Aim
4: Validate treatment planning dose distributions using the compensators from Aim 2 and the
phantoms from Aim 3.

I. INTRODUCTION
As mentioned in Chapter 1, post-mastectomy radiation therapy (PMRT) is the
standard of care for node-positive breast cancer, because it has been shown to markedly
reduce the risk of breast cancer recurrence and mortality2. However, planning and delivering
PMRT is technically difficult. The desired radiation dose distribution should cover the chest
wall and proximal lymph nodes but avoid the heart, lungs, and contralateral breast.
Additionally, the chest wall thickness varies greatly, and large heterogeneities in tissue
density must be accounted for in the treatment plan. Because of these difficulties, most
PMRT plans involve multiple radiation fields that, despite being carefully matched, still
result in hot and cold spots at field junctions6.
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Tissue compensators have been applied in PMRT as one approach to reducing
treatment complexity, improving dose homogeneity, and eliminating hot and cold spots at
field junctions11, 13, 56. Tissue compensators have also been used for similar purposes in a
variety of disease settings, such as cancers of the head and neck14, soft tissue sarcomas17,
total body irradiation18, and paraspinal muscle treatment9. Tissue compensators are versatile
because they can even out almost any surface, which makes simple, single-field treatments
possible19. Despite the dosimetric advantages they provide, however, tissue compensators are
not used frequently. Conventional techniques for compensator fabrication, such as wax
molding and machine milling, are time-consuming and labor-intensive19, and quality
assurance of compensator devices is difficult. While there is a body of literature describing
compensator design algorithms8, 20, these methods are generally not included as part of
commercial treatment planning software.
Three dimensional (3D) printing technology has the potential to overcome the
limitations of conventional fabrication techniques and reduce operational and production
costs compared to conventional fabrication. There is a growing body of research showing
interesting radiotherapy applications of 3D printing, including phantom production27, 28, 30, 31,
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and patient-specific devices20, 22, 24, 37, as well as extensive material analysis20, 44, 45, 52.
The purpose of this chapter was to prove the clinical feasibility of using 3D printed

patient-specific compensators to improve and simplify PMRT. Our aims were to 1) develop
an algorithm to calculate optimal compensator shapes and export them for 3D printing, 2)
compare dose distributions from compensator based plans and clinical plans for actual
patients with varying BMIs, and 3) validate calculated dose distributions with physical
measurements by delivering compensator based plans to patient-specific phantoms.
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II. MATERIALS AND METHODS
A. Algorithm Design
We designed an iterative, 4 step algorithm (Figure 5.1) to calculate patient-specific
compensators. Between each step the user has opportunities to change settings or stop the
script altogether. All but the end of step 4 are implemented as an internal script we wrote in
RayStation 6R (RaySearch Laboratories, Stockholm, Sweden), which is a research version of
the commercial TPS used in our clinic.
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Figure 5.1: Algorithm and compensator planning flow diagram. The 4 steps of the algorithm
are shown, as well as the progression from step 1 to step 2, the iteration between step 2 and
step 3 until satisfactory plan conditions are met, and the final export and printing of the
compensator as shown in step 4.
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Before starting the script a CTV must be defined. Once started, step 1 of the script
will automatically create a new plan and add an electron beam, and then ask the user to set an
appropriate en face gantry angle and isocenter position. Next, the algorithm automatically
creates ROIs designating the cerrobend block and an initial, thin, flat compensator within the
tray. Finally, an initial dose distribution is calculated, and the algorithm moves to step 2.
Step 2 of the algorithm modulates the shape of the compensator according to the
previously calculated dose distribution. The difference between the actual, and prescribed
dose is calculated at the distal edge of the CTV in a grid of user chosen size. Based on this
dose difference, the anterior surface of the compensator is modulated along the ray line
projected to that point. If the dose at the CTV edge is too high, the compensator thickness is
increased, and if it is too low, the compensator thickness is decreased (with a minimum
thickness of 1 mm). Once all grid points have been evaluated and the compensator shape
modulated accordingly, a smoothing function is applied to reduce sharp edges.
Step 3 recalculates the dose in the patient using the newly modulated compensator
shape from step 2. At this point the script pauses, allowing the user to evaluate how well the
plan meets clinical goals. If necessary, the user may change the electron energy or any other
setting. If any settings are changed or if clinical goals are not met, the algorithm will go back
to step 2, then return to step 3. This iterative process continues until the user is satisfied with
the treatment plan.
Once the treatment plan is approved, the patient’s ROI structures are exported and the
compensator ROI is converted into a 3D model using the open-source DICOM image
processing software 3DSlicerRT. Finally, the compensator model is prepared for 3D printing
using the 3D slicing software Simplify3D (Simplify3D; Cincinnati, OH).
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B. Patient Dose Comparisons
Compensator plans were compared with conventional multi-field, multi-energy 3D
plans for a sample of PMRT patients previously treated at our institution. As part of an
Institutional Review Board approved protocol, we selected 8 patients consecutively from a
population of patients treated by the American Board of Radiology (ABR)–certified
collaborating radiation oncologist (WW) between 12/1/2014 and 12/1/2015. The patients all
had left-sided disease, were treated with deep inspiration breath hold, and are representative
of the body mass index range in our clinic.
For each patient’s standard of care treatment plan various dose metrics were recorded,
including CTV coverage, heart dose, ipsilateral and total lung dose, extent of hot spots, skin
dose, and CTV heterogeneity index. Heterogeneity index is defined according to Equation
157.
1)

𝐻𝐼 = 100 ∗

𝐷2 − 𝐷98
𝐷𝑝

D2, D98, and Dp stand for the minimum dose in 2% of the CTV (essentially the
maximum CTV dose), minimum dose in 98% of the CTV (essentially the minimum CTV
dose), and the prescription dose, respectively.
A new plan was then created for each patient using the algorithm described above,
and the same dose statistics were recorded. Differences between each dose metric were tested
for statistical significance using paired t-tests with an applied Bonferroni correction.
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C. Film Profile Measurements
Due to the relatively rapid dose fall off in the distal edge of electron beams, we
wanted to ensure we could accurately model the dose profile in patients when using
compensator devices. To do this we designed a simple wedge shaped compensator in the
TPS, printed it in polylactic acid (PLA), poured cerrobend around it to affix it in the electron
tray, and measured dose profiles in solid water using GAFchromic (Ashland, Bridgewater,
NJ) film. We calibrated our film response using a 16 MeV electron beam in standard output
check conditions. Film profiles were measured by placing film in line with the electron beam,
surrounded by solid water. Five total sheets were irradiated; one at 12 MeV, three at 16 MeV,
and one at 20 MeV. Measured dose profiles were compared with the TPS calculated profiles.

D. Phantom Validation Measurements
In order to validate the full complexity of patient-specific compensators we designed
compensator plans and printed physical compensators for 6 patient-specific anthropomorphic
phantoms. Two phantoms each were based on patients in BMI category 2 (normal weight),
category 3 (overweight) and category 4 (obese). These phantoms were 3D printed using our
previously developed methods as described in Chapter 4, and were based on the same
population of patients described earlier. Both the phantoms and compensators were printed
out of PLA using a Gigabot 3.0 printer (re3D, Houston, TX).
Each phantom was loaded with 20 TLD detectors placed throughout the CTV, heart,
contralateral breast, and skin. For each phantom the compensator plan was delivered as
designed by the previously described algorithm using a Varian TrueBeam linear accelerator
(Varian Medical Systems, Inc., Palo Alto, CA), and the TLD were analyzed following the
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methodology described by Kirby et al.58, having an uncertainty of <2.3%. Dose was also
recorded in the TPS for each TLD location in the phantom, and these calculated and
measured values were compared to determine the ability of the TPS to accurately model dose
in patients for compensator based PMRT plans. The final phantom doses were calculated
with the measured density of the printed phantom corrected in the TPS, according to
recommendations regarding 3D printed devices previously described in Chapter 3.

III. RESULTS
A. Patient Dose Comparisons
Compared to the standard of care clinical plans, the compensator based plans on
average had superior dose coverage of the CTV with reduced hot spots. Statistically
significant (p<0.0025) improvements were achieved for CTV coverage, reduced hot spots in
the lungs, and heterogeneity indices. Results are summarized in Table 5.1.
Figure 5.2 shows all 8 patients’ averaged dose volume histograms comparing the
conventional 3D plan and the compensator based plan. As can be seen in the figure, CTV
coverage is improved, while high dose regions in the lungs and CTV are reduced.
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Table 5.1: Comparison of dose metrics between conventional 3D plans and compensator
based plans.
Dose Metric

Average 3D
Plan

Average Comp
Plan

p-value

4456 cGy
5305 cGy

Average
Difference
(Comp-3D)
555 cGy
74 cGy

CTV D98
CTV Mean
Dose
CTV D2
CTV V45 Gy
Heart Mean
Dose
Heart V30 Gy
Ips. Lung D2
Ips. Lung V20
Gy
Ips. Lung V40
Gy
Total Lung
Mean Dose
Skin Mean Dose
Skin D2
HI
110% Hotspot
Volume
130% Hotspot
Volume
150% Hotspot
Volume

3900 cGy
5231 cGy
6719 cGy
89.07%
280 cGy

6251 cGy
97.08%
296 cGy

-468 cGy
8.01%
16 cGy

0.056
0.001
0.387

0.01%
5209 cGy
30.64%

0.31%
3897 cGy
34.30%

0.30%
-1312 cGy
3.66%

0.057
2.93E-5
0.135

13.31%

1.69%

-11.63%

9.0E-5

748 cGy

760 cGy

12 cGy

0.438

4078 cGy
5773 cGy
56.4
257 cm^3

5223 cGy
6209 cGy
35.9
170 cm^3

1145 cGy
436 cGy
-20.5
-87 cm^3

4.6E-4
0.017
6.1E-4
0.076

32 cm^3

5 cm^3

-27 cm^3

0.087

8 cm^3

0 cm^3

-8 cm^3

0.156

0.001
0.115
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Figure 5.2: Cumulative DVH comparison. The average of all compensator plan DVHs are shown with dotted lines, while the average
of all conventional 3D plans are shown as solid lines. The average standard deviation for conventional 3D plans was 2.47%, and for
compensator plans it was 4.00%.

64

B. Film Profile Measurements
Measured and calculated film dose profiles were compared in 5 ways: depth of the
central 80% isodose line, width of the 80% isodose line, and depth of the 80% isodse line 2
cm to the left and to the right of the central line. The average differences between calculated
and measured dose profiles are shown in Table 5.2. Film measurements and TPS calculations
agreed on average within 2 mm for all energies examined.

C. Phantom Validation Measurements
3D printed compensators took 10-15 hours to print, and material costs averaged $30.
Figure 5.3 shows photographs of a phantom and compensator plan, and TLD results are
summarized in Table 5.3. Average disagreement between TPS and TLD doses in the CTV
was 2.3%, and measured TLD doses outside the treatment area (heart and contralateral
breast) agreed with TPS calculations within 16.9%. Skin TLD pack doses agreed with the
TPS within 2.88%.
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Table 5.2: Film profile measurements and calculation errors.
Energy (MeV)

Average Error (mm)

Standard Deviation (mm)

12

1.27

0.87

16

1.99

1.25

20

1.95

1.17

Average

1.78

1.23

Table 5.3: Summary of TLD dose calculation and measurement error
Phantom

Average
In-field
TLD
Error

In-field
TLD
Error SD

Average
Out-offield TLD
Error

Out-offield
Error SD

Average
Skin TLD
Error

Skin
Error SD

1

1.2%

1.2%

15.7%

8.8%

NA

NA

2

2.5%

1.4%

9.7%

6.6%

1.8%

0.6%

3

2.1%

1.4%

25.0%

24.8%

4.6%

2.0%

4

2.1%

1.3%

20.0%

11.6%

2.7%

1.3%

5

3.5%

2.2%

23.7%

17.0%

3.9%

1.0%

6

2.3%

1.7%

7.2%

9.2%

1.5%

1.8%

Average

2.3%

1.5%

16.9%

13.0%

2.9%

1.4%
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Figure 5.3: Compensator plan delivery to a phantom. A) Photograph of the compensator in
the cerrobend tray. B) Photograph of the compensator and phantom in treatment position, and
C) Slice of the TPS view of the plan. In (C) the compensator is contoured in orange, the
cerrobend in dark blue, the CTV in light blue, and the heart in pink.
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IV. DISCUSSION
In this chapter we developed an in-house algorithm scripted within a commercial TPS
to design patient-specific, 3D printable compensators for PMRT. These compensators are
unique in that they are designed to fit within a standard electron tray, meaning we can use
fast-printing, rigid materials that won’t come in contact with the patient surface. We
additionally validated the dosimetry of the algorithm and 3D printed materials using film
measurements in solid water and TLD measurements in 3D printed, patient-specific
phantoms. Our results show that using 3D printing to fabricate patient specific PMRT
compensators is clinically feasible, and in many ways superior to conventional 3D based
PMRT treatment planning.
There are several advantages to using 3D printed compensators for PMRT treatments
over conventional plans. Dosimetrically, our compensator based plans show improved target
coverage with the prescription dose, and reduced hot spots throughout the patient volume.
While slightly more of the ipsilateral lung receives low dose than in conventional plans, our
compensator plans dramatically reduce the high dose coverage in the lung (Figure 5.2)
because there are no tangent fields passing through the lung volume. Additionally, while the
heart dose is elevated, the difference is not statistically significant and the doses are below all
plan constraints for all cases. One dosimetric disadvantage of using these compensators is the
elevated skin dose relative to conventional plans, which is not always desirable. This can be
reduced by increasing the distance between the compensator and the skin, but this also
negatively affects most other dose metrics.
Beyond dosimetric considerations, compensator plans are easier to set up and align
than conventional multi-field plans due to the fact that there is only one field and one energy.
With further testing the true extent of time saving will be elucidated, but in our experience
68

we were able to set up and deliver a plan to a phantom on average every 15 minutes
compared to the standard 30 minutes scheduled for PMRT patients at our clinic currently.
Another important aspect of this study was the use of 3D printed phantoms to validate
dose calculations using complex, 3D printed, patient-specific compensators. These phantoms
allowed us to accurately reflect the complex anatomy that exists in PMRT treatments, and to
fully validate the accuracy of our treatment plans. Specifically, our film errors (1.99mm), infield TLD errors (2.3%), and skin TLD errors (2.9%) all showed high agreement with TPS
calculations. Our out-of-field TLD agreed within 16.9%±9%, which is acceptable uncertainty
compared to other treatment planning systems and disease sites for out-of-field dose59, 60.
While many advantages exist for 3D printed compensators, there are also some
disadvantages to our system. 3D printing is relatively inexpensive and straightforward, but
does require some level of expertise and investment in resources. Additionally, much care
must be taken to make sure that the unique composition of 3D printed materials is accounted
for with density corrections in the TPS, because as described in Chapter 3, most standard
materials, including PLA, do not fall on the standard CT calibration curve52.
Another consideration is that not all patients can be adequately treated using this
technique. For one of the patients in our study we were unable to meet our ipsilateral lung
dose constraints due to the extreme thinness of the chest wall, and the large curvature of the
full target area. For this patient the use of bolus in conjunction with the compensator could
have improved the dose distribution, but to keep the comparison with other patients identical
this was not attempted. It is important to note, however, that using compensators may not be
possible for all PMRT patients. However, the general methodology and underlying principles
of our algorithm could be easily adapted to multiple other superficial treatment sites such as
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the head and neck, scalp, and extremities, potentially opening up 3D printed based
compensator treatments to a much larger population of patients.

V. CONCLUSION
Our results show the clinical feasibility of using patient specific 3D printed compensators for
PMRT. Specifically, we were able to demonstrate statistically significant improved CTV
coverage and reduced hot spots, as well as a simplified planning and delivery. Additionally,
we found that we could accurately calculate dose in our TPS using custom compensators,
with all in-field TLD errors less than 3%. Additional work must be done to establish a clear
patient workflow and QA procedure, but our results prove that 3D printed compensators are a
clinically acceptable option for PMRT.
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Chapter 6: Discussion
I.

PROJECT OVERVIEW
The purpose of this work was to develop and validate a methodology to deliver

postmastectomy radiation therapy (PMRT) without the currently existing difficulties
associated with conventional 3D planning. This was accomplished in part by utilizing the
unique capabilities of 3D printing technology to rapidly and inexpensively produce custom,
patient-specific compensators. To fulfill this purpose, we started in Aim 1 by characterizing a
variety of 3D printable materials and 3D printers to establish their suitability for radiation
therapy. In Aim 2 we used our results from Aim 1 to design and produce a set of patientspecific PMRT phantoms that could be used to test our new technique. In Aim 3 we
developed an algorithm to design patient-specific compensators, and tested its clinical
feasibility by comparing conventional and compensator based plans for a sample of PMRT
patients. Finally, in Aim 4 we used the phantoms from Aim 2 and the algorithm from Aim 3
to validate dose distributions for compensator based PMRT treatment plans.
Specific Aim 1 was to fully characterize 3D printable materials and 3D printing
processes so that we could accurately and safely use 3D printing technology for radiation
therapy applications. For four different commonly used materials—polylactic acid (PLA),
acrylonitrile butadiene styrene (ABS), NinjaFlex, and Cheetah—we evaluated print accuracy,
material density, average HU, print cost, print time, and application specific parameters like
comfort and rigidity. Additionally, we measured percent depth dose (PDD) curves for
NinjaFlex and PLA on two different linear accelerators (Varian 2100 and Varian TrueBeam)
for the full range of clinical photon and electron energies available at our clinic. Measured
PDDs were compared with TPS calculated PDDs to determine the accuracy of calculating
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dose in 3D printed materials. We discovered from this analysis that there is a wide range in
reproducibility between different materials, and that large variations in fundamental material
properties like density exist even between objects printed under seemingly identical
conditions. We additionally found that, generally speaking, the HU of a 3D printed object
does not accurately predict the density of that object when using standard CT calibration
curves. The relationship between density and HU is linear for most plastics, but it is not
characterized accurately in treatment planning systems. However, we found that by
measuring the density of each specific object, as well as checking its internal structure via CT
imaging, these potential material concerns could be overcome and accurate dose calculations
performed. While a number of other groups have investigated some material properties as
part of their 3D printing research20, 23, 24, 31, 44, 45, 61, we believe that we were the first52 to fully
characterize the potential dosimetric consequences of common 3D printable materials like
NinjaFlex and PLA, and to provide specific quality assurance recommendations to avoid
mistakes induced by material uncertainties.
In Specific Aim 2 we used the results from Specific Aim 1 to select PLA as a suitable
plastic for producing patient-specific compensators and patient-specific phantoms. Next,
using a group of consecutively sampled PMRT patients with a body mass index (BMI) range
representative of our clinic’s PMRT patient population, we designed and 3D printed 6
patient-specific phantoms. For each phantom, patient CT images were first converted into 3D
models. Then, using several pieces of 3D modeling software, each patient model was
sagittaly sliced into 2.5 cm thick slices, and trimmed to be 3D printable. Each phantom
extends from the neck to approximately the naval, with the arms and head removed, but the
shoulders left in place as much as possible to accurately reflect patient positioning. The final
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modeled slices were all 3D printed, and the resultant phantoms were compared with their
original CT data set as well as their planned models. Several other groups have previously
printed phantoms for a variety of purposes, including special imaging tests26, 28, dose
algorithm verification32, IMRT QA27, 48, clinical training29, 30, and many others25, 50, 62, 63.
However, all of these phantoms were limited in size due to a combination of 1) the limited
availability of large scale 3D printers, and 2) material warping considerations when printing
solid objects. Some groups have gotten around these size limitations by printing phantoms in
much smaller pieces, or printing molds28, 30, 62, 64, but this requires much more user effort and
phantom assembly. Our 3D printed phantoms are unique, because we were able to overcome
these size considerations and print full-scale phantoms43. This is largely due to our finding
that sagittal slices print much more reliably than axial slices, and any material errors that do
occur tend to happen on the bottom of the model where they do not interfere with the overall
fit of the slices.
For Aim 3 we first developed an algorithm capable of calculating compensator
models in RayStation (RaySearch Laboratories, Stockholm, Sweden), a research version of
the commercial TPS in use at our clinic. The model was designed to create an initial thin
compensator shape inside the electron tray, and then calculate the dose distribution in the
patient. Based on this initial dose distribution, the compensator shapes were modified to
account for excessively hot or cold spots in the CTV, and then the dose is recalculated in the
patient. At this point the user can evaluate the dose distribution and either approve it or have
the algorithm continue iterating the compensator shape. Once approved, the compensator
shape is exported and prepared for 3D printing. We tested the algorithm using the same
populations of 8PMRT patients from which the 6 patient-specific phantoms were designed.
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For each patient we compared the dose distribution from a compensator plan with their
original standard of care dose distribution, and tested individual metrics for significance with
Bonferroni corrected paired t-tests. We found that relative to the standard 3D plans,
compensator plans had statistically significant improvements in CTV dose coverage, CTV
dose homogeneity, and hot spot reduction in the lungs. We also found that there were not
significant differences in average lung or heart dose between the plan types.
Aim 4 was to validate and ensure the accuracy of the dose distributions calculated in
Aim 3. To achieve this we first designed a simple wedge shaped compensator to fit in a 10
cm × 10 cm electron tray, and used it to irradiate sheets of film using 12 MeV, 16 MeV, and
20 MeV electron beams. We then compared the measured dose profiles with dose profiles
calculated in RayStation. We found that we could accurately calculate the shape of the dose
profile within 2 mm for all measured energies. Next we used the 6 patient specific phantoms
created in Aim 2, and the algorithm created in Aim 3, to design and print 6 compensators.
We delivered the compensator plan to each phantom, and recorded TLD doses in the skin,
CTV, heart, and contralateral breast. Our TLD results were within 3% of planned doses for
all TLD in the treatment area, and were within reasonable uncertainty levels for the out-offield TLD59, 60. This finding shows that we are able to accurately calculate dose distributions
in compensator plans, and when using 3D printed materials.

II.

PROJECT LIMITATIONS
One limitation of using 3D printed materials for radiation oncology is the material

variations. We found in our initial material analysis that PLA blocks printed in identical
conditions on the same printer and using the same roll of filament can vary in density from
74

1.13 g/cm3 to 1.21 g/cm3, with an average of 1.18 g/cm3. For some materials, like Cheetah
and ABS, these variations were considerably smaller, but variations in NinjaFlex were even
larger than in PLA. There are additional variations to consider when using a different printer
or material manufacturer. When identical blocks of PLA were printed using an identical, but
different roll of filament from the same manufacturer as the first roll on an identical, but
different 3D printer from the same manufacturer as the first printer, we observed a similar
range and mean density in blocks. However, when those same blocks models were printed
using a different model of 3D printer using PLA from a different manufacturer, we observed
a mean density of 1.06 g/cm3, which is a greater than 10% difference in density. The two
main concerns with these variations are that 1) any specific material analysis results from one
clinic cannot be translated directly to another clinic because different printers and printer
settings dramatically change material properties, and 2) even after commissioning a 3D
printer a clinic must carefully examine every printed object to determine its specific
correction factors because density can never be assumed. Fortunately, we have shown in this
research that when printers and materials are carefully commissioned they can be used safely,
and while our results cannot be translated to different clinics, our methodology as described
in Chapter 3 and Appendix B can be translated and used elsewhere.
Another limitation of 3D printed materials is that there are limited types available,
and they are generally not tissue equivalent. Of the various materials examined in this study,
none of them could be considered to be radiologically water equivalent. One of the key
findings of our material analysis was that CT calibration curves for treatment planning
systems do not accurately predict the density of 3D printed objects. Even if one material
could be found that is entirely equivalent to some specific tissue type, humans are made up of
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a variety of tissues with varying densities and HU levels, ranging from the nearly air
equivalent lungs, to bones and possibly even metal implants. The phantoms we printed were
homogenous in all the bony and soft tissue areas of the body, which is by necessity a
simplification somewhere (see Table 4.2). Even dual-material phantoms, which we have
previously shown to be generally inferior in several characteristics45, 48, 65-67, are necessarily
simplifying everything but one soft-tissue density and one bone density. However, even
conventionally fabricated radiation oncology and imaging phantoms are made up of a
discrete number of materials which don’t entirely accurately represent human tissue, not just
3D printed ones. For our purposes, and likely many other use cases, the advantage of being
able to easily create patient-specific anatomical shapes was more important than being able
to exactly model interior tissue composition.
The elevated skin dose we observed in the compensator plans relative to patients’
conventional plans is another limitation of this study. The average dose to the skin in our
sample’s conventional plans was 81.5% of the prescription dose. For the compensator plans,
there was a statistically significant increase to 104.46% of the prescription dose. The
maximum dose (D2%) in the skin was similarly increased for the compensator plans from
115.45% to 124.18% of the prescribed dose; however, this difference was not statistically
significant (Table 5.2). Skin reactions are one of the most common side effects of breast and
chest wall irradiation, and can be debilitating68-70. Furthermore, skin reactions are directly
correlated with dose71, 72. For some patients it is desirable to escalate skin dose in order to
irradiate all potential microscopic disease and reduce the risk of chest wall recurrences68, and
this is traditionally accomplished by using bolus in conjunction with conventional treatment
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planning. However, skin dose escalation is not uniformly used and if compensators are to be
used regularly, the skin dose will already be elevated and so all potential skin sparing is lost.

III.

FUTURE DIRECTIONS
While the primary objective of this project was accomplished, there are several

related questions left to be explored. These questions tend to fit into three main categories: 1)
additional 3D printing material and technology research, 2) continuation and perfection of
PMRT compensator development, and 3) additional treatment sites and opportunities for
patient-specific devices.

A. 3D Printing and Technology Research
Mentioned as a limitation earlier in this chapter, it has been well established that 3D
printing materials have highly variable material properties, and that they are not tissue
equivalent. However, this work has detailed research into only four materials, and one type
of 3D printing technology. While FDM printing is the least expensive and most accessible
type of 3D printing, many more expensive options exist that may provide more reliable or
tissue-equivalent material, and there are dozens of available materials for FDM that we have
not tested. An interesting and open question is if any of these other myriad options would be
superior in quality than our findings. In general, continuing to characterize new materials and
3D printers should be a priority to take full advantage of the potential applications of 3D
printing.
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B. Clinical Implementation of 3D Printed PMRT Compensators
In order for 3D printed PMRT compensators to be readily adopted in the clinic there
are several steps that first must be taken. First of all, the compensator design algorithm
detailed in Chapter 5 must be made to be more user-friendly, and much faster. The algorithm
as currently written (Appendix E) uses ROI addition and subtraction to determine the
position of the anterior and posterior surfaces of the compensator, CTV, and prescription
isodose line. This is a time consuming calculation, and is performed along each ray line
several times as the check ROI progresses along the line because these positions are not
known a priori. A better calculation would determine the proximity of the check ROI to each
of these points with a single calculation, thus reducing calculation time by more than an order
of magnitude. Another time limitation is that several steps of the algorithm currently require
user input. Steps like assigning the gantry angle, setting the SSD, and checking to see if plan
constraints have been met could theoretically be automated in the future. Additionally, the
algorithm is currently implemented in RayStation 5.99, but the newest version, RayStation 7,
allows for direct STL export of ROIs. Updating the algorithm to be used in RayStation 7
could make it possible to avoid using any other software.
As part of the algorithm process we had to commission a new machine with shortened
electron applicators. This was because RayStation does not allow ROI volumes to intersect
the area of the electron applicator, and the compensators are designed to fit in the electron
tray with the cerrobend poured around them. To get around this we commissioned a new
TrueBeam machine with shortened electron applicators, and we design the cerrobend tray as
part of the algorithm. Our TLD and film results have shown that this process can be used to
accurately calculate dose. However, this machine is only commissioned for research use. It
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would have to be commissioned for clinical use, or a new build of RayStation tested and
approved for clinical use that allows ROIs in the electron tray before PMRT compensators
can be clinically used.
Another difficulty of this process is the preparation of the compensator in the tray and
the actual clinical implementation. Generally the treatment planning system prepares a
template for electron blocks that make it simple to pour the cerrobend in the right place, but
because our machine’s electron applicators are shortened this rendering is incorrect. To align
the compensator in the electron tray we rendered the cerrobend ROI on a grid, captured a
screenshot of that, and printed it to scale on several pieces of paper. We then taped the pieces
of paper together, and aligned the grid with the electron tray. This process worked, but was
time consuming and is potentially sensitive to human error. There is no reason this could not
also be automated as part of the script to produce the same document as is produced for other
electron plans to simplify compensator placement in the tray. Once the compensator is in the
tray, making sure that patients are aligned with the tray is also important. For our phantoms
we used external fiducials and known shifts, and then checked that against our expected SSD.
This is not always possible with patients, and some form of image guided alignment will
likely be necessary. This needs to be developed and implemented.
A final question regarding clinical implementation of PMRT compensators is
deciding which patients are eligible for it. Will all patients be planned with conventional 3D
plans, and then only poor cases be referred for compensators? This adds much time and
reduces the simplicity advantage that compensators and the algorithm provide. Or perhaps all
patients will initially be planned with compensators and poor cases will be referred to 3D
planning? Again, this is a potential waste of time and resources if it could be known ahead of
79

time which patients would benefit most from which treatment type. It seems likely that some
criteria, such as thickness and curvature of chest well, depth of CTV, or skin surface
complexity, could be used to determine the optimal treatment modality for patients before
planning so that each type of plan can be taken full advantage of.

C. Additional Treatment Sites and Devices
Separate from PMRT, there are several other disease sites that could be treated using
3D printed patient-specific compensators. Additionally, there are several other 3D printable
patient-specific devices that could be used to improve radiation therapy. One example of this
is making surface based patient-specific compensators. We explored this possibility some,
and have detailed those experiments in Appendix C, but there is much work left to be done,
including adapting the algorithm to fit compensators on the skin, and validating dose
measurements. Additional improvements into printing with NinjaFlex, which we used, or
finding a different material suitable for surface based treatments, would also be required.
Another interesting potential use of these PMRT compensators is to not treat the
whole volume of CTV with one electron compensator, and instead use the compensator to
just combine multiple IMC fields. Most of the chest wall would still be treated with photon
tangents, but the IMC would be treated with a 3D printed compensator. The IMC fields
would be reduced from multiple non-conformal fields to a single conformal field. This
adaptation would be more similar to current treatment techniques, while still providing
clinical value. Additionally, IMC specific compensators would be smaller, making them
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much easier to design, faster to print, and less expensive than compensators covering the full
CTV.
Patient-specific compensators could also be used in a variety of treatment sites other
than the chest wall. Previously, Su et al.20 have demonstrated the utility of 3D printing a
compensator for a pediatric rhabdomyosarcoma case, showing a mean reduction in dose to
the left kidney of 38.2% relative to conventional bolus. Zhao et al.33 have 3D printed patientspecific comepensators for a number of disease sites, including a squamous cell carcinoma of
the nasal septum, a basal cell carcinoma of the posterior pinna, and a mycosis fungoides
involving the upper face. 3D printing has also been used by Zou et al.23 to treat superficial
cancer around the ear, and previously our group has reported the use of a 3D printed neck
bolus for total body irradiation73. However, in all of these cases the bolus was designed to be
conformal to the skin, and not in the electron tray. If these sites could be treated using
compensators of our design that fit into the electron tray, they could perhaps be further
simplified and improved.

IV.

CONCLUSIONS
In this work we developed a new methodology to design patient-specific

compensators for PMRT that fit in the electron tray rather than the surface of the patient. We
additionally validated this methodology using 3D printed, patient-specific phantoms loaded
with TLD. Our results show that patient-specific compensators can be used to significantly
improve and simplify radiation therapy for postmastectomy patients. Specifically, we have
demonstrated improvements in CTV coverage, CTV homogeneity, and reduction in hot spots
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in the lungs. Average skin dose was also significantly increased for the compensator plans,
but changes in hot spots in the skin were insignificant. Additionally, we have shown that it is
possible to fabricate these compensators using 3D printing technology, and that we can
accurately calculate dose distributions using 3D printed compensators and patient-specific
phantoms, despite potentially large variations in the material properties of 3D printed objects.
These results show that with proper quality assurance and testing, 3D printing technology can
be used to fabricate patient-specific compensators that can improve dose distributions in
patients receiving postmastectomy radiation therapy.
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Appendix A: Patient Dose Data
Patient 1
Table A.1: Patient 1 Dose and Planning Data
Metric

Conventional Plan

Compensator Plan

Nominal Electron Energy (MeV)

NA

12

Gantry Angle

NA

29.2

SSD (cm)

NA

99

MU/fx

NA

195

CTV D98 (cGy)

4103

4400

CTV Average Dose (cGy)

5299

5087

CTV D2 (cGy)

6781

5899

CTV V45 (%)

88.78

95.1

Heart Average Dose (cGy)

240

360

Heart V30 (%)

0

0.22

Ipsilateral Lung Average Dose (cGy)

1634

1685

Ipsilateral Lung D2 (cGy)

5587

3894

Ipsilateral Lung V20 (%)

32.52

39.86

Ipsilateral Lung V40 (%)

13.95

0.84

Total Lung Average Dose (cGy)

918

862

110% Hotspot Volume (cm3)

333.52

49.76

130% Hotspot Volume (cm3)

24.69

0

150% Hotspot Volume (cm3)

0

0

Skin Average Dose (cGy/Gy)

75.66

100.8

Skin D2 (cGy/Gy)

120.18

115.6

CTV Heterogeneity Index

53.56

29.98
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Figure A.1: Patient 1 3D and compensator plan DVH.
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Figure A.2: Axial slice of Patient 1 3D and compensator plan dose distributions. The 110%,
90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and white
colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose lines
are shown as red and purple lines, respectively. The CTV is also shown in light blue.
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Patient 2
Table A.2: Patient 2 Dose and Planning Data
Metric

Conventional Plan

Compensator Plan

Nominal Electron Energy (MeV)

NA

9

Gantry Angle

NA

22.0

SSD (cm)

NA

99

MU/fx

NA

234

CTV D98 (cGy)

3959

4450

CTV Average Dose (cGy)

5302

5470

CTV D2 (cGy)

6609

6717

CTV V45 (%)

92.82

97.26

Heart Average Dose (cGy)

234

376

Heart V30 (%)

0

0.37

Ipsilateral Lung Average Dose (cGy)

1380

1605

Ipsilateral Lung D2 (cGy)

5208

3848

Ipsilateral Lung V20 (%)

26.73

38.06

Ipsilateral Lung V40 (%)

10.89

0.76

Total Lung Average Dose (cGy)

696

841

110% Hotspot Volume (cm3)

160.21

139.09

130% Hotspot Volume (cm3)

8.42

13.48

150% Hotspot Volume (cm3)

0

0

Skin Average Dose (cGy/Gy)

103.9

115.26

Skin D2 (cGy/Gy)

130.06

139.02

CTV Heterogeneity Index

53

45.34
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Figure A.3: Patient 2 3D and compensator plan DVH.
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Figure A.4: Axial slice of Patient 2 3D and compensator plan dose distributions. The 110%,
90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and white
colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose lines
are shown as red and purple lines, respectively. The CTV is also shown in light blue.
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Patient 3
Table A.3: Patient 3 Dose and Planning Data
Metric

Conventional Plan

Compensator Plan

Nominal Electron Energy (MeV)

NA

9

Gantry Angle

NA

25.8

SSD (cm)

NA

99

MU/fx

NA

219

CTV D98 (cGy)

3946

4450

CTV Average Dose (cGy)

5302

5497

CTV D2 (cGy)

6818

6510

CTV V45 (%)

88.98

97.56

Heart Average Dose (cGy)

242

139

Heart V30 (%)

0.04

0

Ipsilateral Lung Average Dose (cGy)

1673

1101

Ipsilateral Lung D2 (cGy)

5184

3678

Ipsilateral Lung V20 (%)

34.24

26.21

Ipsilateral Lung V40 (%)

16.45

0.38

Total Lung Average Dose (cGy)

792

549

110% Hotspot Volume (cm3)

228.6

206.18

130% Hotspot Volume (cm3)

20.67

4.75

150% Hotspot Volume (cm3)

1.56

0

Skin Average Dose (cGy/Gy)

71.12

111.82

Skin D2 (cGy/Gy)

112.98

129.42

CTV Heterogeneity Index

57.44

41.2
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Figure A.5: Patient 3 3D and compensator plan DVH.
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Figure A.6: Axial slice of Patient 3 3D and compensator plan dose distributions. The 110%,
90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and white
colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose lines
are shown as red and purple lines, respectively. The CTV is also shown in light blue.
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Patient 4
Table A.4: Patient 4 Dose and Planning Data
Metric

Conventional Plan

Compensator Plan

Nominal Electron Energy (MeV)

NA

12

Gantry Angle

NA

31.9

SSD (cm)

NA

99

MU/fx

NA

208

CTV D98 (cGy)

3520

4400

CTV Average Dose (cGy)

4985

5230

CTV D2 (cGy)

5883

6149

CTV V45 (%)

83.69

96.2

Heart Average Dose (cGy)

296

387

Heart V30 (%)

0.04

0.35

Ipsilateral Lung Average Dose (cGy)

1118

1400

Ipsilateral Lung D2 (cGy)
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Figure A.7: Patient 4 3D and compensator plan DVH.
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Figure A.8: Axial slice of Patient 4 3D and compensator plan dose distributions. The 110%,
90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and white
colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose lines
are shown as red and purple lines, respectively. The CTV is also shown in light blue.
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Patient 5
Table A.5: Patient 5 Dose and Planning Data
Metric

Conventional Plan

Compensator Plan

Nominal Electron Energy (MeV)

NA

12

Gantry Angle

NA

23.0

SSD (cm)

NA

100

MU/fx

NA

206

CTV D98 (cGy)

3440

4500

CTV Average Dose (cGy)

4993

5119

CTV D2 (cGy)

5899

6035

CTV V45 (%)

82.21

98

Heart Average Dose (cGy)

281

483

Heart V30 (%)

0.01

1.39

Ipsilateral Lung Average Dose (cGy)

1314

1581

Ipsilateral Lung D2 (cGy)

4941

4259

Ipsilateral Lung V20 (%)

27.16

34.94

Ipsilateral Lung V40 (%)

11.25

6.08

Total Lung Average Dose (cGy)

574

753

110% Hotspot Volume (cm3)

71.16

66.75

130% Hotspot Volume (cm3)

0.77

0.5

150% Hotspot Volume (cm3)

0

0

Skin Average Dose (cGy/Gy)

66.16

100.78

Skin D2 (cGy/Gy

100.94

117.64

CTV Heterogeneity Index

49.18

30.7
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Figure A.9: Patient 5 3D and compensator plan DVH.
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Figure A.10: Axial slice of Patient 5 3D and compensator plan dose distributions. The
110%, 90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and
white colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose
lines are shown as red and purple lines, respectively. The CTV is also shown in light blue.
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Patient 6
Table A.6: Patient 6 Dose and Planning Data
Metric

Conventional Plan

Compensator Plan

Nominal Electron Energy (MeV)

NA

12

Gantry Angle

NA

18.9

SSD (cm)

NA

99.5

MU/fx

NA

225

CTV D98 (cGy)

4226

4500

CTV Average Dose (cGy)

5549

5579

CTV D2 (cGy)

8515

6568

CTV V45 (%)

94.68

98

Heart Average Dose (cGy)

409

185

Heart V30 (%)

0

0

Ipsilateral Lung Average Dose (cGy)

1991

1527

Ipsilateral Lung D2 (cGy)

5837

3800

Ipsilateral Lung V20 (%)

39.6

35.77

Ipsilateral Lung V40 (%)

19.63

0.51

Total Lung Average Dose (cGy)

1017

818

110% Hotspot Volume (cm3)

825.35

473.78

130% Hotspot Volume (cm3)

163.97

16.47

150% Hotspot Volume (cm3)

56.73

0

Skin Average Dose (cGy/Gy)

81.14

93.72

Skin D2 (cGy/Gy)

121.96

130.1

CTV Heterogeneity Index

85.78

41.36
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Figure A.11: Patient 6 3D and compensator plan DVH.
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Figure A.12: Axial slice of Patient 6 3D and compensator plan dose distributions. The
110%, 90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and
white colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose
lines are shown as red and purple lines, respectively. The CTV is also shown in light blue.
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Patient 7
Table A.7: Patient 7 Dose and Planning Data
Metric

Conventional Plan

Compensator Plan

Nominal Electron Energy (MeV)

NA

9

Gantry Angle

NA

22.5

SSD (cm)

NA

99.25

MU/fx

NA

224

CTV D98 (cGy)

4369

4500

CTV Average Dose (cGy)

5396

5548

CTV D2 (cGy)

7282

6557

CTV V45 (%)

95.92

98

Heart Average Dose (cGy)

250

118

Heart V30 (%)

0

0.01

Ipsilateral Lung Average Dose (cGy)

1554

1053

Ipsilateral Lung D2 (cGy)

5140

3929

Ipsilateral Lung V20 (%)

32.13

24.47

Ipsilateral Lung V40 (%)

13.47

1.48

Total Lung Average Dose (cGy)

692

485

110% Hotspot Volume (cm3)

219.46

227.93

130% Hotspot Volume (cm3)

38.36

7.24

150% Hotspot Volume (cm3)

2.83

0

Skin Average Dose (cGy/Gy)

101.38

110.68

Skin D2 (cGy/Gy)

133.78

130.66

CTV Heterogeneity Index

58.26

41.14

101

100

Percent Volume Irradiated

90

CTV

80

Heart

70

Ipsilateral Lung

60

Total Lung
CTV Comp

50

Heart Comp
40

Ipsilateral Lung Comp
30

Total Lung Comp

20
10
0
0

1000

2000

3000

4000

5000

6000

7000

8000

Dose (cGy)
Figure A.13: Patient 7 3D and compensator plan DVH.
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Figure A.14: Axial slice of Patient 7 3D and compensator plan dose distributions. The
110%, 90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and
white colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose
lines are shown as red and purple lines, respectively. The CTV is also shown in light blue.
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Patient 8
Table A.8: Patient 8 Dose and Planning Data
Metric

Conventional Plan

Compensator Plan

Nominal Electron Energy (MeV)

NA

12

Gantry Angle

NA

29.4

SSD (cm)

NA

99

MU/fx

NA

190

CTV D98 (cGy)

3644

4450

CTV Average Dose (cGy)

5022

4913

CTV D2 (cGy)

5964

5574

CTV V45 (%)

85.49

96.5

Heart Average Dose (cGy)

288

320

Heart V30 (%)

0

0.11

Ipsilateral Lung Average Dose (cGy)

1540

1813

Ipsilateral Lung D2 (cGy)

5145

4092

Ipsilateral Lung V20 (%)

30.73

42.93

Ipsilateral Lung V40 (%)

14.02

3.15

Total Lung Average Dose (cGy)

767

1030

110% Hotspot Volume (cm3)

123.57

14.12

130% Hotspot Volume (cm3)

2.35

0

150% Hotspot Volume (cm3)

0

0

Skin Average Dose (cGy/Gy)

79.34

97.7

Skin D2 (cGy/Gy)

105.14

110.56

CTV Heterogeneity Index

46.4

22.48
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Figure A.15: Patient 8 3D and compensator plan DVH.
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Figure A.16: Axial slice of Patient 8 3D and compensator plan dose distributions. The
110%, 90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and
white colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose
lines are shown as red and purple lines, respectively. The CTV is also shown in light blue.
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Appendix B: 3D Printing Material Analysis Procedure
When commissioning a new material for 3D printing it is important to consider several
factors, including print accuracy, print consistency, material density, material HU, material
stopping power, and other application-specific needs. The following guide describes a way to
ensure material properties are well understood before use. Our overall procedure is to a)
evaluate the material’s overall suitability, b)determine the print consistency and accuracy of
an object, c)measure CT based metrics, and d)measure percent depth doses.

I.

MATERIAL OVERVIEW

When a new material is first obtained the user should attempt to print several simple
objects, like blocks, cylinders, or simple geometric shapes. After iterating several attempts, a
“best practice” can be determined. The best printing practice can vary significantly between
materials, and includes things like bed temperature, nozzle temperature, print speed, infill
percentage, infill pattern, flow rate, and more. These factors can strongly affect the internal
material properties of a printed object, so once they are decided it is important to keep them
consistent unless you also want to retest the material.
At this point it is also appropriate to evaluate the overall quality of the material for its
intended purpose. If it is intended to be used in patient contact, is it comfortable? If it is
going to be used to hold things, is it rigid and strong? If it will be used often, does it print
well, or does the printer need lots of “babying” with it? These questions should be addressed
before continuing.
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II.

MATERIAL PRINTING CHARACTERISTICS

Once a material’s overall suitability has been considered it is important to consider
printing accuracy. For this step the user will define and print a sample of at least 5 simple
objects, preferably cubes or boxes on a similar scale to objects the material is intended for.
The 5 objects should be compared for print consistency, and evaluated for density and print
accuracy. When determining material density the dimensions should be measured to
determine volume, not assumed to be accurate from the intended model. Print accuracy can
be defined in 2 main ways: physical accuracy and CT based accuracy.
1) Physical Accuracy:
Physical measurement metrics of print accuracy are determined by measuring the actual
dimensions of printed objects with accurate calipers and comparing with the dimensions of
the intended model. These metrics should include the directionality of measurement for
linear metrics. For example, if an object is 1 mm larger than intended, it is important to know
if that is in the plane parallel with the printing bed or perpendicular to the printing bed. Also,
it is generally more useful to report these errors in absolute scale (mm), rather than in percent
difference, because the scale of errors for most materials is similar regardless of object size.
Physical measurement accuracy can also be reported as a volume, where percent error is
more meaningful because it correlates to overall density.
2) CT Based Accuracy:
Sometimes CT based measurements are more useful. For example, if the intended object
is a patient-specific device modeled in a treatment planning system, it is important that the
CT based rendering of the device be similar to the intended model. For CT based metrics, the
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object should be CT imaged using standard protocols, and then the resulting image should be
converted to a 3D file format in the same way the original model would be designed. Several
software options exist for this including blender, Osirix, Slicer, and others. The resulting
printed object model can then be compared with the intended object model. As with
measured errors, these errors can be reported as linear dimensions, or volumetrically.

III.

CT BASED METRICS

If a material is not going to be used in a radiation environment, the remaining steps are
unnecessary. If an object’s radiological properties are of interest, a CT of the blocks used to
determine print accuracy is the first step. Each of the 5 blocks should be contoured in the CT
exam, with the exact protocol determined by the material’s intended use. If, for example, the
entire object will be used, a threshold based contouring technique may be valuable. If known
print errors exist in the bottom centimeter or so of an object and that area won’t be in-beam,
perhaps leaving it out of the contour is more appropriate. Whatever contouring technique is
used, it should be consistently applied.
Once contoured, the average HU and standard deviation should be measured for each
block. Additionally, the CT should be visually examined to make sure there aren’t regions in
the blocks with holes or print inconsistencies.
The average HU of each block should be plotted against its measured density, and
compared with the standard CT calibration curve for that CT scanner. This is a vital step to
take, to make sure that materials are behaving as you would predict. If necessary, this may
indicate to the user of any specific QA practices that need to be employed.
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IV.

PERCENT DEPTH DOSE MEASUREMENTS

If a material is going to be used in the beam path as a treatment related device, it is
important to measure the percent depth dose of various clinical beams in that material. This is
important, because it allows the user to guarantee that radiation interacts with the material in
the way that the treatment planning system predicts. To determine this with certainty there
are three steps. First, measurements are taken in the material, second, material specific
correction factors are applied to determine PDD, and third, measured PDDs are compared
with PDDs modeled in that material by the TPS.
The PDD measurement can be taken several ways, but again should be consistent once
established. Our technique is described here. First, 5 material blocks are printed. Object A
has dimensions of 20 cm by 20 cm by 2.5 cm. Object B and C are both 5 cm by 20 cm by 2.5
cm. Object D is 5 mm by 20 cm by 2.5 cm, and object E is 3 mm by 20 cm by 2.5 cm.
Objects A, B, and C have holes in them for ion chamber placement. The width of the hole
depends on the ion chamber being used. Our blocks are designed with a 6 mm A1SL in mind.
Renderings of these objects are shown in Figure B.1.
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Figure B.1: The 5 PDD measurement blocks. Part A has a single hole placed for 5 cm of
material above and beneath, Part B has a hole for 1 cm above, and 4 cm beneath, and part C
has a hole for 2 cm above, and 3 cm beneath. Parts D and E have no holes. All ion chamber
holes extend 10 cm deep into the middle of the block.
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These blocks can be stacked in various orders with an ion chamber placed in one of
the holes to achieve a large range of measurement depths. For example, B-C-A can be used
for 1 cm deep. C-B-A can be used for 2 cm. For 3 cm, use “upside down C”-B-A. For
smaller resolution, employ blocks D and E as needed. One irradiation position is shown in
Figure B.2. For all measurement points we place solid water sheets on either side of the
printed blocks, and we take 3 measurements at each point of at least 100 MU each. All beam
energies that an object might be used in should have PDD measurements done.
Determining the PDD for photons is a simple matter of dividing each data point by
the highest data point, but for electrons some manual corrections need to be applied. To
determine the actual PDD for electron beams we follow the protocol outlined in TG 25. The
Prepl. error correction is taken from tables in TG 2546, and the material specific stopping
power ratio correction factors are taken from NIST’s online modeling software ESTAR47.
To model the material in the TPS and compare PDDs, a CT should be taken of the
PDD blocks with solid water around them. That CT can then be used to create a simple AP
plan like was used to perform the PDD measurements. Calculate what the TPS thinks the
PDD in that material should be, and compare that with what was actually measured. For
some materials, the density for the material may need to be manually overridden in order to
get good agreement, as was likely noticed while measuring CT based metrics in Section III
(also see Chapter 3).
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Figure B.2: Percent depth dose measurement set-up. In this photograph, the ion chamber was
inserted into the top hole at the 1-cm depth position. Holes not occupied by the ion chamber
were plugged with acrylic rods to avoid air gaps. Solid water (brown) sheets were positioned
on either side of the NinjaFlex to ensure scatter equilibrium.
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V.

CONCLUSION

Once a material has been shown to fit the application specific needs, can be printed
accurately and consistently, and can be accurately modeled in the TPS, you are ready to go. It
is important to remember that any new material, new printer, or even a dramatically different
new use case my require repeating most or all of the steps listed above. Never assume that a
3D printed objects precise material properties can be known without being examined, and
remember that internal defects may not be obvious even after measuring the density, so a CT
is almost always necessary. With these rules and guidelines in mind, 3D printing can be safe,
and very productive in radiation therapy.

114

Appendix C: Surface Compensator Studies
I.

INTRODUCTION
In the previously unpublished study described below, we explored the option of

designing and using 3D printed compensators that fit on the patient’s skin instead of in the
electron tray. These compensators were designed to be made out of NinjaFlex, a flexible and
soft material that would be more comfortable for patients rather than the relatively more rigid
PLA that has been described earlier. In the end the decision was made not to pursue surface
based compensators for several reasons: NinjaFlex is more difficult to print with than PLA,
NinjaFlex is more expensive than PLA, NinjaFlex takes much longer to print than PLA,
surface based compensators can be harder to align and keep in place than rigid ones, and
finally because there were concerns regarding the skin dose from using a surface
compensator for each patient. Regardless of these limitations, the methods, results, and a
brief conclusion of the research performed regarding 3D printed, soft, surface compensators
is described below.

II.

METHODS AND MATERIALS

A. Basic Material Analysis
We printed 5 cm × 5 cm × 5 cm cubic blocks of the flexible thermoplastic NinjaFlex
(NinjaTek, Manheim, PA). NinjaFlex cubes were printed on an FDM style Gigabot 2.0
printer (re3D, Houston, TX) using a 0.40 mm nozzle, 100% infill, 0.20 mm layer height, and
0.8 mm wall thickness.
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We tested NinjaFlex for print accuracy, physical density, and Hounsfield units (HU).
We also evaluated the print speed and cost. Print accuracy was defined as the largest
absolute Euclidean distance discrepancy between the designed and printed object, as
measured by sub-millimeter resolution calipers. We also used these measured dimensions
and the measured mass of the blocks to determine the physical density of the printed
material. Material cost and print speed were determined by the actual price paid for the
material, and printer settings were taken directly from the recommendations of the material
manufacturing companies.
A computed tomography (CT) image was acquired for each block on a Philips
Brilliance Big Bore (Philips Healthcare, Andover, Massachusetts) and the average HU was
measured from that image. We contoured each block with a 2-mm buffer from the edge and
determined the average HU and its standard deviation. For comparison, we assessed the
average chest wall HU for a group of five clinical PMRT patients at our institution. As part
of an Institutional Review Board–approved protocol, the patients were selected consecutively
from a population of patients treated by the American Board of Radiology (ABR)–certified
collaborating radiation oncologist (WW) between 12/1/2014 and 12/1/2015. The patients are
representative of the body mass index range in our clinic.
To evaluate the flexibility and printability of the NinjaFlex material, we printed a
large compensator for an anthropomorphic phantom. This simple compensator was designed
to make the entire surface of the chest flat with respect to an anterior beam.
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B. Percent Depth Dose Measurements
To perform percent depth dose (PDD) measurements we printed several much larger
blocks of NinjaFlex. One 20 cm × 20 cm × 2.5 cm block and two 20 cm × 5 cm × 2.5 cm
blocks were printed of each of the two materials. When stacked, the printed blocks of each
material formed a sheet 30 cm tall, 20 cm long, and 2.5 cm wide. One 5 mm × 2.5 cm × 20
cm block and one 3 mm × 2.5 cm × 20 cm was also printed for each of the two materials. At
our in-house machine shop, holes were drilled in each of the three larger blocks to
accommodate a small volume ion chamber, the Exradin A1SL (Standard Imaging Inc.,
Middleton, WI). The holes within the blocks were drilled such that with various stacking
orders the ion chamber could be positioned a depths of 1 to 11 cm at 1-cm increments. By
adding the 5-mm or 3-mm strips on top of the other blocks, 0.3-cm measurement increments
were possible.
For each depth, we took three measurements with a calibrated (National Institute of
Standards and Technology (NIST) traceable) A1SL ion chamber for each electron and
photon energy available in our clinic. All measurements were performed on two Varian
2100 linear accelerators (Varian Medical Systems, Palo Alto, CA) for 6- and 18-MV photon
energies and 4, 6, 7, 9, 11, 12, 16, and 20 MeV electrons. Note that, for all measurements,
solid water sheets were positioned on either side of the printed blocks to ensure scatter
equilibrium. Holes not occupied by the ion chamber were plugged with acrylic rods to avoid
air gaps. All measurements were performed with a 100-cm source-to-surface distance (SSD)
and using a 10 cm × 10 cm electron applicator.
For each ion chamber reading, the dose was calculated by following the protocol in
the American Association of Physicists in Medicine Task Group 25 report46. Because the

117

precise chemical make-up of NinjaFlex is not known and because the density is very close to
water, water-to-air stopping power ratios were used. Then, a PDD curve was calculated for
each beam energy by normalizing the dose at each depth to the maximum dose.

C. Comparison of Measured and Calculated Percent Depth Doses
To ensure the capacity of the treatment planning system to accurately calculate dose
within NinjaFlex, a CT image was acquired of the blocks using the same set-up configuration
that was used to measure PDD (Section III.B). For this work, all calculations were performed
using a commercial treatment planning system, Pinnacle3 V9.10 (Philips Healthcare,
Andover, Massachusetts). This is the primary planning system at our institution for photon
and electron dose calculations and is fully commissioned for clinical use. A single-field
treatment plan was created at every available electron and photon energy for the blocks of
NinjaFlex. NinjaFlex seemed to be correctly modeled, so the sole input to the treatment
planning system for each treatment plan was the acquired CT of the set-up conditions used in
Section III.B to measure PDD (i.e., 100 cm SSD, 10 cm × 10 cm electron applicator for
electron beams). The calculated dose corresponding to each measurement point was recorded
for all plans and then a PDD curve was calculated by normalizing the dose at each depth to
the maximum dose.

D. Compensator Design and Fabrication
We designed a PMRT compensator from the CT scan of the anthropomorphic
phantom. The collaborating radiation oncologist (WW), who specializes in breast radiation
oncology, delineated a clinical target volume (CTV) on the phantom CT that was
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representative of a typical PMRT CTV, including the internal mammary chain (IMC) vessels
levels I-III and the chest wall.
We used a simple ray-tracing method to design a compensator that achieved a
uniform antero-posterior thickness of 5 cm from the compensator surface to the distal edge of
the contoured CTV. This thickness was chosen because it corresponds closely with the 90%
depth dose of our 16 MeV electron beam and was sufficiently deep so there weren’t any
holes in the compensator design. We used the ATOM male dosimetry anthropomorphic
phantom (CIRS Tissue Simulation and Phantom Technology, Norfolk, VA) for which the
arm position could not be adjusted, resulting in a CTV that was much deeper than would be
observed in an actual patient whose arm would be raised out of the treatment area, allowing
the use of a shallower depth and therefore thinner compensator. Nonetheless, for a proof of
principle study this methodology was reasonable, and works well for delineating the surface
of the phantom.
The compensator design was converted to the standard tessellation language (.STL)
file format that most 3D printers use by using OsiriX software (Pixmeo; Bernex,
Switzerland). The 3D printing software Simplify3D (Cincinnati, OH) was then used to
generate machine code (commonly referred to as g code) which provides the 3D printer with
a series of commands for printing the compensator and a variety of support structures around
it to ensure print accuracy. The g code was transferred to the Gigabot 2.0 printer, and the
compensator was printed with the flexible NinjaFlex filament. The compensator was printed
with its inferior border on the printing bed, because this arrangement minimizes warping.
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E. Compensator Validation
To ensure the capacity of the treatment planning system to accurately calculate dose
with a NinjaFlex compensator in place and to validate the accuracy of our complex 3Dprinted compensator, we created and delivered a simple single-electron field PMRT plan.
The printed compensator was placed on the anthropomorphic phantom, and a CT image was
acquired. A 16 MeV single-field electron PMRT plan was created by an ABR–certified
clinical medical physicist (RMH) whose specialty is breast radiation therapy. The plan was
reviewed and approved by the radiation oncologist (WW). The treatment was delivered
according to the plan using a clinical Varian 2100 to the anthropomorphic phantom with the
compensator in place.
Thermoluminescent dosimeters (TLD) were placed throughout the phantom during
irradiation. The TLD were read by following the methodology described by Kirby et al.58.
Measured TLD doses were then compared with doses predicted by the treatment planning
system to assess the consistency of the compensator planning and placement.

F. Compensator Plan Comparison
We next compared the compensator plan with two current standard-of-care PMRT
techniques used at our institution. The additional treatment plans were calculated for the
phantom by a certified medical dosimetrist (JK) whose specialty is breast radiation therapy.
Specifically, we considered two conventional radiation therapy planning techniques that are
routinely used in our clinic, photon tangents with an electron IMC field and a three-field
electron technique. The first comparison plan used a mixed photon/electron technique with
electron IMC fields split (because of differing CTV depths) into an 11 MeV upper portion
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and a 7 MeV lower portion matched to two tangential photon fields that were mixed 6- and
18-MV energies with field-in-field modulation. The three-field electron technique consisted
of electron fields covering the IMC split into a 9 MeV upper portion and a 6 MeV lower
portion, a 4 MeV medial chest wall electron field, and a 9 MeV lateral chest wall electron
field. The prescription was 50 Gy to the chest well and IMC. The beam design for the two
comparison treatment plans are shown in Figure C.1, along with the single-field electron
compensator plan.

a.

b.

c.

Figure C.1: 3D skin rendering showing the treatment fields for the standard-of-care and
compensator plans: (a) The photon/electron plan, (b) the three-field electron plan, and (c) the
single-field 16 MeV electron compensator plan.

The treatment plans were evaluated by various metrics such as mean chest wall and
IMC doses, chest wall and IMC volumes receiving 90% of the prescribed dose (V90), and
dose to 2% of the chest wall and IMC. Additionally, isodose curves were evaluated for CTV
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coverage as well as for presence of hot and cold spots throughout the treatment area, in
particular at the field junctions for the standard-of-care plans.

III.

RESULTS

A. Basic Material Analysis
The basic properties of the materials studied and patient sample are listed in Table
C.1.

Table C.1: Physical and radiological properties of a range of 3D printable plastics compared
to a sample of PMRT patient chest walls.

Material
Patient chest
wall tissue
a

Mean
HU±1SD
-32±67

Physical Density
3

(g/cm )
water/muscle:1.00,
fat: 0.92a

Print
Error
(mm)

Print
Speed

Material
Cost

N/A

N/A

N/A

NinjaFlex
-107±21
1.04
0.09
25 mm/s
Physical densities for water/muscle and fat were taken from the literature74

$87/kg

NinjaFlex was identified as a viable material based on physical density, HU similar to
soft tissue, and low print error. The NinjaFlex material additionally is flexible and thus, we
anticipate, more conformable to irregular PMRT surfaces. Because compensators for PMRT
must be conformable to highly irregular surfaces, a flexible material is better suited for
PMRT than a rigid material. Also, a property that is not well represented by the table or
figure but is nonetheless important in material selection is that the NinjaFlex is “softer” to the
touch and thus would be more comfortable when placed on a patient’s skin.
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B. Comparison of Measured and Calculated Percent Depth Doses
The calculated PDD curves (solid lines) are shown next to the corresponding
measured curves (triangles) in NinjaFlex in Figure C.2. Measurements in NinjaFlex agreed
with calculated curves within 2 mm for all electron energies, except for 20 MeV where
differences up to 4 mm were observed. Measurements in 6- and 18-MV photon beams agreed
within 2%.
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Figure C.2: PDD curves in NinjaFlex are shown as calculated in the treatment planning
system (solid lines) and as measured (triangles). (a) shows calculated and measured curves in
NinjaFlex for low-energy electron beams (4, 6, 7, and 9 MeV), (b) shows measured and
calculated PDDs for high-energy electron beams (11, 12, 16, and 20 MeV), and (c) show 6and 18-MV photon beams.
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C. Compensator Design and Fabrication
We printed a flexible NinjaFlex compensator with maximum dimensions of 22 × 21 ×
15 cm with negligible (< 1 mm) material warping based on comparing measurable design
dimensions. The printing took ~70 hours and cost less than $75 in material. The compensator
bends easily but completely restores its shape when pressure is removed.

D. Compensator Validation
The printed compensator fit well on the phantom, with no air gaps greater than 2 mm
as measured by CT. Figure C.3 shows the compensator on the phantom, as well as the 16
MeV single-field electron plan. The compensator had an average HU of -115±13, which is
very similar to the measured block (Table C.1). The compensator is overall very
homogenous, with some small heterogeneities visible. The TLD measurements agreed well
with doses predicted by the treatment planning system. TLD placed within the CTV agreed
with predicted doses within 5%, and more distal TLD located in the lung and heart agreed
within 12%.
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Figure C.3: The 3D printed compensator plan in the (a) sagittal plane and (d) axial plane
with triangles indicating positions of TLD during irradiation. (b) is a photograph of the
compensator on the anthropomorphic phantom during irradiation. The CTV is shown as
shaded contours: IMC levels I-III and chest wall are red. The heart is shown in shaded
purple. The 45 Gy (90%) isodose line is shown as a thick yellow line. (c) and (e) show
similar planes as (a) and (d), but without the treatment plan obscuring the homogeneity of the
printed compensator or its fit on the phantom.
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E. Compensator Plan Comparison
The three treatment plans were compared for mean chest wall and IMC doses, chest
wall and IMC volumes receiving 90% of the prescribed dose, dose to 2% of the chest wall
and IMC, and presence of hot and cold spots throughout the treatment area. These results are
summarized in Table C.2.

Table C.2: Summary of various dose metrics for the three treatment plan techniques
compared in this study. For all plans, the prescribed dose to the IMC and chest wall (CW)
CTV was 50 Gy. The Dmean is the mean dose in Gy to the volume. The V90 is the percent
volume receiving 90 percent of the prescribed dose. D2 is the dose in Gy to 2% of the
volume.

Photon/Electron
Plan

3-Field Electron Plan

Single-field
Electron
Compensator Plan

50.87±4.79

45.16±10.82

46.79±5.88

53.74±2.46

49.10±2.14

49.44 ±3.68

CW V90 (%)

89.8

60.1

70.5

IMC V90 (%)

99.4

96.9

89.0

CW D2 (Gy)

57.65

66.15

56.95

IMC D2 (Gy)

59.55

54.70

56.25

Dose Metric
CW Dmean±1SD
(Gy)
IMC Dmean±1SD
(Gy)
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The photon/electron and three-field electron plans both yielded larger and more
extreme hot and cold spots than the compensator plan. The compensator plan had one hot
spot that reached up to 114% of the prescribed dose in the area of the phantom’s left arm.
The photon/electron plan showed hot spots at the junction between the IMC fields and at the
junction between the IMC and medial to lateral tangent. These hot spots exceeded 120% of
the prescribed dose. The three-field electron plan had the most hot spots, with 120% hot
spots at the junctions between the IMC, medial, and lateral fields, as well as between the
upper and lower IMC fields. One hot spot between the medial and lateral fields exceeded
130% of the prescribed dose. Additionally, the three-field electron plan had cold spots
adjacent to each hot spot. These hot and cold spots can be seen in Figure C.4, which shows
representative axial and sagittal views of each treatment plan (same views shown for all
plans).
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Figure C.4: Comparison of the isodose distributions from the three treatment plans evaluated
in this study. The CTV is contoured in shaded red, while the 45 Gy (90%) isodose line is
shown in thick yellow. Hot spots of 120% and 110 % are illustrated by magenta and blue
isodose lines, respectively. The photon/electron plan is shown in (a) axial and (b) sagittal
views; the three-field electron plan in (c) axial and (d) sagittal views; and the single-field
compensator plan in (e) axial and (f) sagittal views. Note the greater presence of hot spots in
both the three-field electron and photon/electron plans than in the single-field compensator
plan.
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IV.

DISCUSSION
In this study we demonstrated the feasibility of designing and 3D printing a full-scale,

large PMRT compensator with flexible NinjaFlex material for an anthropomorphic phantom.
Additionally, we compared a single-field electron compensator treatment plan with two
standard-of-care plans and demonstrated that the single-field electron compensator plan is a
suitable option for PMRT. Together, these findings demonstrate the clinical feasibility of 3D
printed compensators for PMRT.
Previous studies applying 3D-printing technology to fabricate tissue compensators20,
22-24

have considered only rigid printable materials. Here, we demonstrated that flexible

materials can be used to 3D print large-volume compensators for a large anatomical site such
as the chest wall in PMRT. We found that NinjaFlex approximates the properties of soft
tissue well and is flexible, allowing for a more conformal and comfortable fit on the patient’s
body surface. Despite being flexible, we found that NinjaFlex was relatively incompressible
and restored its shape exactly even after being deformed many times. The PDD curves
measured in NinjaFlex agreed very well with calculated PDDs. It also exhibited almost no
material warping during printing. The main drawback of using NinjaFlex is the long print
times; equivalent solids take about three times longer to print with NinjaFlex than with PLA
or ABS.
Designing and printing a simple compensator to achieve uniform thickness to the
distal edge of the desired CTV was straightforward. The print time of such a large object is,
however, a current limitation of 3D printing. NinjaFlex requires particularly slow print
speeds, so the compensator took nearly 70 hours to print. However, this limitation is likely to
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lessen because of the precipitously increasing library of available printing materials and the
rapid development of 3D printing technology.
A limitation of this study is that the method we used to design the compensator did
not account for electron scatter, true SSD, or tissue heterogeneities in the phantom. Another
limitation of our study is that we used an anthropomorphic phantom whose arm position
necessitated that our compensator be designed for use with a 16 MeV electron beam in order
to penetrate to the most distal part of the chest wall CTV. This high-energy beam caused a
correspondingly higher heart and lung dose than we otherwise would have expected.
Designing a compensator for a phantom analogous to a PMRT patient, i.e., ipsilateral arm
raised, would allow use of lower energy and less-penetrating electrons, such as 9 or 12 MeV.
This would have several beneficial dosimetric effects. First and most importantly, dose to the
lungs and heart would be reduced. Additionally, the overall thickness of the compensator
would be substantially reduced, leading to a shorter print time and lower material costs.

V.

CONCLUSIONS
In this study, we 3D printed an actual full-size PMRT compensator of flexible, tissue-

equivalent plastic and demonstrated that a single-field compensator plan with this
compensator performed well compared to two standard-of-care treatment techniques. The
compensator had an average HU of -115 ± 13, and calculated PDDs in the material agreed
with measured values within 2 mm for all electron energies up to 20 MeV. TLD
measurements from the delivered compensator plan agreed with planned doses within 5%
within the CTV. The results of this study demonstrated that 3D printing can be used to
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produce chest wall compensators that make simple, single-electron field plans a viable
clinical option for PMRT. With continued material testing and improved compensator design
algorithms, dose distributions will be improved for PMRT patients, and compensator use will
be possible for a range of additional treatment sites.
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Appendix D: Algorithm Use Instructions
The algorithm as currently written (Appendix E) is designed to run as a
semiautomatic script in RayStation version 6R (named 5.99 Proton in Citrix). This appendix
serves as an informal instruction manual on using the algorithm and preparing a compensator
to be 3D printed.
First of all, there are a number of conditions that must be met in order for the
algorithm to work as designed.
Algorithm Conditions:
1) Patient be left-sided
2) Patient have External and CTV_eval contours defined
3) Planning CT be named “CT 1”
4) Have an existing plan open in RayStation
5) Don’t have any plans named “comp plan”, or any ROIs named “Compensator” or “ecutout”
a. Alternately, if you just want to modify a compensator but not create the plan
from scratch, make sure you have all of the above items, as well as a
calculated dose distribution.
If these conditions are met, you can start the algorithm by navigating to its file
location in the scripting interface and pressing play. Shortly after you will get a message that
looks like this:
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At this point move to the “plan design” tab and select the newly created “comp plan,”
then navigate to the “Electron Beam Design” tab. Rotate the gantry angle of the beam in
order to create the most evenly en face angle possible. Next open the “T&P Settings” menu,
mark the check box for “Apply margin settings to all beams,” and but 2.5 into the Y2 box. It
should look like the screen shot below.

Under “Settings” make sure the number of monte carlo histories is at least 10,000,
and press OK. Finally set the SSD to skin to be 100 cm, then press “conform all beams.”
Now navigate back to the scripting menu, and press the play button to resume the script. Now
the script will create an ROI representing the electron cerrobend cutout as well as the
compensator, which can take a few minutes.
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When the initial ROI shapes of the electron cut out and compensator are completed a
pop up box like this will show up.

Open the ROIs tab on the left, and double click on Compensator. In the ROI
properties menu under “Material,” select PLA, then press OK. Next select the ROI
“e_cutout” and set its material to cerrobend. Both of those ROIs should now have a star next
to them, and look like this in the list. Once that is done, press play again in the scripting tab.

Next the script will calculate the dose distribution in the patient. At this point you can
examine the shape of the dose distribution yourself, and see if any parts of the compensator
can be thickened or thinned out a lot to start out with. Be very careful to not over do things,
but it can save a lot of time by reducing iterations if you manually modify the shape of the
compensator now to give it a bit of a best guess to start with. When you are satisfied, click
OK on the pop up message warning you this is the last step, and then press play again on the
scripting menu.
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This is now the iterative part of the algorithm. The script will run through the whole
compensator and determine which sections need to be made thicker and which sections need
to be made thinner. Once that has been determined it will alter the shape of the compensator
accordingly, and then recalculate dose. Then the script is finished and closes. The user then
examines the dose distribution in the patient as well as any relevant dose metrics. If desired,
the user may also modify the shape of the compensator ROI if again it is obvious that it needs
to be much thicker or thinner is some place. If any adjustments are made make sure to
recalculate dose before continuing. If the user is unsatisfied with the dose distribution, reopen
the script and play it again. It will start at the point of modulating the compensator shape as
long as it detects a Compensator ROI already exists. Once you are satisfied with the plan and
compensator, export the DICOM data. You don’t need to export the plan and dose, but you
need the CT and the ROI structure sets.
Next open 3D Slicer. Press the purple button in the top left that says DCM, then
import and load the DICOM of the patient that was just exported. Under modules open
“Segmentations.” On the right hand side open the export/import tab, select models, and press
export. It should look like this.
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Now click on the “Save” button on the top left with the red arrow. Deselect
everything except the Compensator ROI, set its file format to be .STL, choose the directory
you want the file to go, and press save. Open the saved .STL file in Simplify3D, and set all
the settings to below.

Finally, press “Prepare to Print,” save the .gcode file to an SD card, put it in the 3D
printer, and print the compensator.
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Appendix E: Algorithm Code
This is the unabridged IronPython code for the RayStation script that designs the
compensators. As much as possible it has been commented to explain what is going on.
##This Python code can be used to calculate compensator shapes for left sided PMRT
patients, BUT IS NOT CLINICALLY APPROVED. DO NOT USE THIS CODE FOR
CLINICAL APPLICATIONS.
from connect import *
import math
import copy
############################
#This first function creates the compensator plan and beam set, as well as the first
compensator shape
def comp_init():
case = get_current("Case")
examination = get_current("Examination")
with CompositeAction('Add Treatment plan'):
newplan = case.AddNewPlan(PlanName="comp plan", PlannedBy="", Comment="",
ExaminationName=examination.Name, AllowDuplicateNames=False)
newplan.SetDefaultDoseGrid(VoxelSize={ 'x': 0.3, 'y': 0.3, 'z': 0.3 })
beam_set = newplan.AddNewBeamSet(Name="comp plan", ExaminationName="CT 1",
MachineName="TBModApplicators", Modality="Electrons",
TreatmentTechnique="ApplicatorAndCutout", PatientPosition="HeadFirstSupine",
NumberOfFractions=25, CreateSetupBeams=True,
UseLocalizationPointAsSetupIsocenter=False, Comment="", RbeModelReference=None,
EnableDynamicTrackingForVero=False)
beam_set.AddDosePrescriptionToRoi(RoiName="CTV_eval", DoseVolume=0,
PrescriptionType="NearMinimumDose", DoseValue=4500, RelativePrescriptionLevel=1,
AutoScaleDose=True)
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# CompositeAction ends
#now we need to calculate the isocenter first pass guess
structure_set=newplan.GetStructureSet()
ctv_cent=structure_set.RoiGeometries["CTV_eval"].GetCenterOfRoi()
iso_position = {'x':ctv_cent.x, 'y':ctv_cent.y, 'z':ctv_cent.z}
electron_energy=12
with CompositeAction('Add beam (electron beam, Beam Set: comp plan)'):
newbeam = beam_set.CreateElectronBeam(ApplicatorName="Varian 25x25 85 end",
Energy=electron_energy, InsertName="cutout1", IsAddCutoutChecked=True,
IsocenterData={ 'Position': iso_position, 'NameOfIsocenterToRef': "", 'Name': "comp plan
1", 'Color': "98, 184, 234" }, Name="electron beam", Description="", GantryAngle=0,
CouchAngle=0, CollimatorAngle=0)
newbeam.SetBolus(BolusName="")
await_user_input('Change gantry angle as appropriate, move the isocenter, set the SSD to
100, and set monte carlo histories.')
#now we read the gantry angle to use in the shift calculations
gantry_angle_deg=beam_set.Beams['electron beam'].GantryAngle
gantry_angle=gantry_angle_deg*math.pi/180
#now we add the compensator
plan = get_current("Plan")
#here is where we form the first guess of what the compensator will look like, imbedded into
the electron insert
comp_guess2(case, examination, beam_set)
#now we set the comp ROI properties. Note that the materials setting isn't a particular
material, but where it falls on the list. this seems like a problem
with CompositeAction('Apply ROI changes (compv1)'):
case.PatientModel.RegionsOfInterest['Compensator'].Type = "Fixation"
case.PatientModel.RegionsOfInterest['Compensator'].OrganData.OrganType = "Other"
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await_user_input('Set the Compensator ROI material to be PLA, and the electron cutout to
cerrobend.')
# CompositeAction ends
#for now we aren't computing dose because the applicator won't let it work anyway
beam_set.ComputeDose(ComputeBeamDoses=True,
DoseAlgorithm="ElectronMonteCarlo", ForceRecompute=False)
################################
#this comp guess is the one that creates the compensator and electron cutout with the comp in
the insert
def comp_guess2(case, examination, beam_set):
#both the e_cutout and compensator ROIs are labelled as Fixation, but material
designation must be done manually by the user
spot = beam_set.Beams['electron beam'].Isocenter.Position
with CompositeAction('Create Box ROI (electron_cutout)'):
retval_0 = case.PatientModel.CreateRoi(Name="electron_cutout", Color="Magenta",
Type="Fixation", TissueName=None, RoiMaterial=None)
retval_0.CreateBoxGeometry(Size={ 'x': 25, 'y': 2, 'z': 25 }, Examination=examination,
Center={ 'x': 0, 'y': 0, 'z': spot.z })
# CompositeAction ends
ssd = 100
comp_shift = ssd-96.25
gantry_angle_deg=beam_set.Beams['electron beam'].GantryAngle
gantry_angle=gantry_angle_deg*math.pi/180
rotate_mat = {'M11':math.cos(gantry_angle), 'M12':-math.sin(gantry_angle), 'M13':0,
'M14':spot.x+comp_shift*math.sin(gantry_angle),
'M21':math.sin(gantry_angle), 'M22':math.cos(gantry_angle), 'M23':0,
'M24':spot.y-comp_shift*math.cos(gantry_angle),
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'M31':0, 'M32':0, 'M33':1, 'M34':0,
'M41':0, 'M42':0, 'M43':0, 'M44':1}
case.PatientModel.RegionsOfInterest["electron_cutout"].TransformROI3D(Examination=exa
mination, TransformationMatrix=rotate_mat)

#now we need to delete out a cavity for the CTV
with CompositeAction('Expand (CTV)'):
retval_0 = case.PatientModel.CreateRoi(Name="CTV_copy", Color="SaddleBrown",
Type="Organ", TissueName=None, RoiMaterial=None)
retval_0.CreateMarginGeometry(Examination=examination,
SourceRoiName="CTV_eval", MarginSettings={ 'Type': "Expand", 'Superior': .5, 'Inferior':
0.5, 'Anterior': 0.5, 'Posterior': 0.5, 'Right': 0.5, 'Left': 0.5 })
# CompositeAction ends
with CompositeAction('Expand (CTV)'):
retval_1 = case.PatientModel.CreateRoi(Name="CTV_copy2", Color="SaddleBrown",
Type="Organ", TissueName=None, RoiMaterial=None)
retval_1.CreateMarginGeometry(Examination=examination,
SourceRoiName="CTV_eval", MarginSettings={ 'Type': "Expand", 'Superior': .4, 'Inferior':
0.4, 'Anterior': 0.4, 'Posterior': 0.4, 'Right': 0.4, 'Left': 0.4 })
with CompositeAction('Expand (CTV_copy2)'):

case.PatientModel.RegionsOfInterest['CTV_copy2'].CreateMarginGeometry(Examination=e
xamination, SourceRoiName="CTV_copy2", MarginSettings={ 'Type': "Expand", 'Superior':
2, 'Inferior': 2, 'Anterior': 2, 'Posterior': 2, 'Right': 2, 'Left': 2 })
# CompositeAction ends

with CompositeAction('Contract (CTV_copy2)'):
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case.PatientModel.RegionsOfInterest['CTV_copy2'].CreateMarginGeometry(Examination=e
xamination, SourceRoiName="CTV_copy2", MarginSettings={ 'Type': "Contract",
'Superior': 2, 'Inferior': 2, 'Anterior': 2, 'Posterior': 2, 'Right': 2, 'Left': 2 })
# CompositeAction ends
# CompositeAction ends
yshift = -.5*math.cos(gantry_angle)
xshift = .5*math.sin(gantry_angle)
shift_mat = {'M11':1, 'M12':0, 'M13':0, 'M14':xshift,
'M21':0, 'M22':1, 'M23':0, 'M24':yshift,
'M31':0, 'M32':0, 'M33':1, 'M34':0,
'M41':0, 'M42':0, 'M43':0, 'M44':1}
for n in range(0,20):
#now we expand ctv_copy into electron cutout. We will repeat this step after each shift.
with CompositeAction('ROI Algebra (Compensator)'):

case.PatientModel.RegionsOfInterest['CTV_copy2'].CreateAlgebraGeometry(Examination=e
xamination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames':
["CTV_copy2"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0,
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames':
["CTV_copy"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0,
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Union", ResultMarginSettings={
'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 })
#with CompositeAction('ROI Algebra (electron_cutout)'):
#case.PatientModel.RegionsOfInterest['electron_cutout'].CreateAlgebraGeometry(Examinati
on=examination, Algorithm="Auto", ExpressionA={ 'Operation': "Union",
'SourceRoiNames': ["electron_cutout"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0,
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation':
"Union", 'SourceRoiNames': ["CTV_copy"], 'MarginSettings': { 'Type': "Expand", 'Superior':
0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } },
ResultOperation="Subtraction", ResultMarginSettings={ 'Type': "Expand", 'Superior': 0,
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 })
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case.PatientModel.RegionsOfInterest["CTV_copy"].TransformROI3D(Examination=examin
ation, TransformationMatrix=shift_mat)
# CompositeAction ends

with CompositeAction('Delete ROI (CTV_copy)'):
retval_0.DeleteRoi()
# CompositeAction ends
with CompositeAction('ROI Algebra (cutoutregion)'):
retval_0 = case.PatientModel.CreateRoi(Name="cutoutregion", Color="Orange",
Type="Organ", TissueName=None, RoiMaterial=None)
retval_0.SetAlgebraExpression(ExpressionA={ 'Operation': "Intersection",
'SourceRoiNames': ["electron_cutout", "CTV_copy2"], 'MarginSettings': { 'Type': "Expand",
'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={
'Operation': "Union", 'SourceRoiNames': [], 'MarginSettings': { 'Type': "Expand", 'Superior':
0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="None",
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior':
0, 'Right': 0, 'Left': 0 })
retval_0.UpdateDerivedGeometry(Examination=examination, Algorithm="Auto")
# CompositeAction ends
with CompositeAction('Delete ROI (CTV_copy2)'):
case.PatientModel.RegionsOfInterest['CTV_copy2'].DeleteRoi()
# CompositeAction ends
with CompositeAction('ROI Algebra (e_cutout)'):
retval_1 = case.PatientModel.CreateRoi(Name="e_cutout", Color="Blue",
Type="Fixation", TissueName=None, RoiMaterial=None)
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retval_1.SetAlgebraExpression(ExpressionA={ 'Operation': "Union",
'SourceRoiNames': ["electron_cutout"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0,
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation':
"Union", 'SourceRoiNames': ["cutoutregion"], 'MarginSettings': { 'Type': "Expand",
'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } },
ResultOperation="Subtraction", ResultMarginSettings={ 'Type': "Expand", 'Superior': 0,
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 })
retval_1.UpdateDerivedGeometry(Examination=examination, Algorithm="Auto")
# CompositeAction ends
with CompositeAction('Delete ROI (electron_cutout)'):
case.PatientModel.RegionsOfInterest['electron_cutout'].DeleteRoi()
# CompositeAction ends
with CompositeAction('Contract (cutoutregion)'):
retval_2 = case.PatientModel.CreateRoi(Name="cutcutcut", Color="Blue",
Type="Organ", TissueName=None, RoiMaterial=None)
retval_2.CreateMarginGeometry(Examination=examination,
SourceRoiName="cutoutregion", MarginSettings={ 'Type': "Contract", 'Superior': 0.3,
'Inferior': 0.3, 'Anterior': 0.3, 'Posterior': 0.3, 'Right': 0.3, 'Left': 0.3 })
# CompositeAction ends
with CompositeAction('Apply ROI changes (cutoutregion)'):
case.PatientModel.RegionsOfInterest['cutoutregion'].Name = "Compensator"
case.PatientModel.RegionsOfInterest['Compensator'].Type = "Fixation"
case.PatientModel.RegionsOfInterest['Compensator'].OrganData.OrganType = "Other"
# CompositeAction ends
for n in range(0,2):
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#now we delete out from compensator. We will repeat this step after each shift.
with CompositeAction('ROI Algebra (Compensator)'):
case.PatientModel.RegionsOfInterest['Compensator'].CreateAlgebraGeometry(Examination=
examination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames':
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior':
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union",
'SourceRoiNames': ["cutcutcut"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0,
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } },
ResultOperation="Subtraction", ResultMarginSettings={ 'Type': "Expand", 'Superior': 0,
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 })
case.PatientModel.RegionsOfInterest["cutcutcut"].TransformROI3D(Examination=examinati
on, TransformationMatrix=shift_mat)
# CompositeAction ends
with CompositeAction('Delete ROI (cutcutcut)'):
case.PatientModel.RegionsOfInterest['cutcutcut'].DeleteRoi()
##############################
#this first section creates the mover and mover2 ROIs and puts it at the initilization point,
and also creates the addition and subtraction ROIs
def create_mover(mover_position, case):
with CompositeAction('Create Sphere ROI (mover)'):
mover_ROI = case.PatientModel.CreateRoi(Name="mover", Color="Green",
Type="Organ", TissueName=None, RoiMaterial=None)
#mover_ROI.CreateSphereGeometry(Radius=0.15, Examination=examination,
Center={ 'x': mover_position[0], 'y': mover_position[1], 'z': mover_position[2] })
with CompositeAction('Create Sphere ROI (mover2)'):
mover2_ROI = case.PatientModel.CreateRoi(Name="mover2", Color="Orange",
Type="Organ", TissueName=None, RoiMaterial=None)
#mover2_ROI.CreateSphereGeometry(Radius=0.15, Examination=examination,
Center={ 'x': mover_position[0], 'y': mover_position[1], 'z': mover_position[2] })
with CompositeAction('Create Sphere ROI (addition)'):
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addition_ROI = case.PatientModel.CreateRoi(Name="addition", Color="Cyan",
Type="Organ", TissueName=None, RoiMaterial=None)
with CompositeAction('Create Sphere ROI (subtraction)'):
subtraction_ROI = case.PatientModel.CreateRoi(Name="subtraction", Color="Orange",
Type="Organ", TissueName=None, RoiMaterial=None)
##############################
#this returns 0 if we are not in Compensator, and returns 1 if we are in Compensator
def check_mover_in_Compensator(case, plan):
position = 0
structure_set=plan.GetStructureSet()
with CompositeAction('ROI Algebra (mover)'):
case.PatientModel.RegionsOfInterest['mover'].CreateAlgebraGeometry(Examination=exami
nation, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames':
["mover"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0,
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames':
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior':
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction",
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior':
0, 'Right': 0, 'Left': 0 })
try:
vol = structure_set.RoiGeometries['mover'].GetRoiVolume()
if vol <.1:
position = 1
except:
position = 1
#wrods = str(vol)#this can be used to check the volume of the mover each time it steps if
you are concerned there are problems
#await_user_input(wrods)
return position
##############################
#this returns 0 if we are not in compensator, and returns 1 if we are in compensator
def check_mover2_in_comp(case, plan):
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position = 0
structure_set=plan.GetStructureSet()
with CompositeAction('ROI Algebra (mover2)'):
case.PatientModel.RegionsOfInterest['mover2'].CreateAlgebraGeometry(Examination=exam
ination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames':
["mover2"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0,
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames':
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior':
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction",
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior':
0, 'Right': 0, 'Left': 0 })
try:
vol = structure_set.RoiGeometries['mover2'].GetRoiVolume()
if vol <.014:
position = 1
except:
position = 1
return position
#############################
#this returns 2 of we are in CTV_eval, and returns 1 if we are partially out of CTV IT IS
SUPER IMPORTANT THAT THIS IS THE OPPOSITE OF THE CHECK THAT THE
OTHER ONE DOES
def check_mover_in_CTV(case, plan, mover_position, CTV_count1, structure_set):
#the position=0 if not in vtest, 1 if in vtest
position = 2
with CompositeAction('ROI Algebra (mover)'):
case.PatientModel.RegionsOfInterest['mover'].CreateAlgebraGeometry(Examination=exami
nation, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames':
["mover"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0,
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames':
["CTV_eval"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0,
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'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction", ResultMarginSettings={
'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 })
vol = 0
try:
vol = structure_set.RoiGeometries['mover'].GetRoiVolume()
if vol > .01:
position = 1
except:
position = 2
if vol > .1 and CTV_count1>10:
case.PatientModel.RegionsOfInterest['mover'].CreateAlgebraGeometry(Examination=exami
nation, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames':
["mover"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0,
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames':
["External"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0,
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction", ResultMarginSettings={
'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 })
try:
vol = structure_set.RoiGeometries['mover'].GetRoiVolume()
if vol < .002:#for this to trigger: mover is not in CTV, and is in external. in that case,
if the dose is also super low, we are done with this point
check_point = {'x':mover_position[0], 'y':mover_position[1],
'z':mover_position[2]}
check_dose_odd =
plan.TreatmentCourse.TotalDose.InterpolateDoseInPoint(Point=check_point)
check_dose = math.ceil(check_dose_odd)#this rounds up to the nearest cGy, which
just makes the math simpler
if check_dose < 1000:
position = 3
except:
check_point = {'x':mover_position[0], 'y':mover_position[1], 'z':mover_position[2]}
check_dose_odd =
plan.TreatmentCourse.TotalDose.InterpolateDoseInPoint(Point=check_point)
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check_dose = math.ceil(check_dose_odd)#this rounds up to the nearest cGy, which
just makes the math simpler
if check_dose < 1000:
position = 3

return position

###########################
#this script assumes your position is not currently in the compensator or test ROI. It moves
the mover according to the gantry angle until it reaches the CTV, then continues to move it
#until it is no longer in the CTV. At that point, it checks the dose, then decides to add to
addition points the intial point or not
def CTV_in_then_out(case, plan, mover_position, addition_points, beam_set, machine_db,
examination, dgan_angle, structure_set):
current_surface_point = mover_position[:]
mover_position=move_mover(mover_position, dgan_angle, case, examination)
hot_dose = 1
CTV_count1 = 0
CTV_count2 = 20
while (CTV_count1<40):
position = check_mover_in_CTV(case, plan, mover_position, CTV_count1,
structure_set)#position =1 if not in CTV, and not in a cold spot in external, position=2 if in
the ctv, position=3 if not in the ctv, but in external and dose is low
CTV_count1 = CTV_count1+1
if position == 2: ##this position being 2 means you are now in the CTV, so it sets
current count to 15 so it stops, then sets the next count to 0 so it can happen
CTV_count1 = 40
CTV_count2 = 0
#await_user_input('We are now in the CTV!')#this can be used to check the script
if position == 3: #this means that you are in the external and dose is low, so far from
treatment area
CTV_count1 = 20#end this while loop, and don't let the next one start
149

else: ##if you are still not in the CTV, you move the mover another step
mover_position = move_mover(mover_position, dgan_angle, case, examination)
while (CTV_count2<20): #this should only happen if you progress to being inside the
CTV. At this point you move it and continue until outside
mover_position = move_mover(mover_position, dgan_angle, case, examination)#you
want to start by moving it, because the last position was 0 so you might as well start with a
step
position = check_mover_in_CTV(case, plan, mover_position, CTV_count2,
structure_set)
CTV_count2 = CTV_count2+1
if CTV_count2 == 20:
await_user_input("The CTV seems to be unusually thick somewhere and we are stuck.
Try again.")
if position == 1: #in this case position = 1 means we are now OUT of the CTV. for this
if to work, we must have first entered the test roi, then exited the CTV
dose_threshold = 4800
#await_user_input('We are now checking the dose at this point!')#this can be used to
check the script
hot_dose = point_dose_check(dose_threshold, mover_position, plan, beam_set,
machine_db) #hot_dose will be 1 if the dose is fine, and 2 if the dose is hot
CTV_count2 = 20
return hot_dose
########################
#this takes the current center position of mover, then moves it according to gantry
angle(eventually), then returns the new mover_position list
def move_mover(mover_position, dgan_angle, case, examination):
#dia is the circle diameter
dia=.3
rgan_angle=dgan_angle*math.pi/180
mover_position[0] = mover_position[0]-.5*dia*math.sin(rgan_angle)
mover_position[1] = mover_position[1] + .5*dia*math.cos(rgan_angle)
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case.PatientModel.RegionsOfInterest['mover'].CreateSphereGeometry(Radius=dia,
Examination=examination, Center={ 'x': mover_position[0], 'y': mover_position[1], 'z':
mover_position[2] })
return mover_position
######################
#this takes the current center position of mover, then moves it according to gantry
angle(eventually), then returns the new mover_position list
def move_mover2(mover_point, dgan_angle, case, examination):
#dia is the circle diameter
dia=.3
rgan_angle=dgan_angle*math.pi/180
mover_point[0] = mover_point[0]-.9*dia*math.sin(rgan_angle)
mover_point[1] = mover_point[1] + .9*dia*math.cos(rgan_angle)
case.PatientModel.RegionsOfInterest['mover2'].CreateSphereGeometry(Radius=dia/2,
Examination=examination, Center={ 'x': mover_point[0], 'y': mover_point[1], 'z':
mover_point[2] })
return mover_point
######################
#this script is supposed to be used after the cutting one to smooth out the Compensator ROI.
It contracts it 2 mm, then expands it 2 mm, except in the posterior direction it expands it
more, then deletes external
def comp_smoother(case, examination):
with CompositeAction('Expand (Compensator, Image set: CT 1)'):

case.PatientModel.RegionsOfInterest['Compensator'].CreateMarginGeometry(Examination=
examination, SourceRoiName="Compensator", MarginSettings={ 'Type': "Expand",
'Superior': 0.4, 'Inferior': 0.4, 'Anterior': 0.4, 'Posterior': 0.4, 'Right': 0.4, 'Left': 0.4 })
with CompositeAction('Contract (Compensator, Image set: CT 1)'):

case.PatientModel.RegionsOfInterest['Compensator'].CreateMarginGeometry(Examination=
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examination, SourceRoiName="Compensator", MarginSettings={ 'Type': "Contract",
'Superior': 0.4, 'Inferior': 0.4, 'Anterior': 0.4, 'Posterior': 0.4, 'Right': 0.4, 'Left': 0.4 })
with CompositeAction('ROI Algebra (e_cutout, Image set: CT 1)'):

case.PatientModel.RegionsOfInterest['e_cutout'].CreateAlgebraGeometry(Examination=exa
mination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames':
["e_cutout"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0,
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames':
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior':
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction",
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior':
0, 'Right': 0, 'Left': 0 })
######################
#this sub script takes the list of points on the surface of vtest and subtracts the addition points
from them
def COMP_cutter(case, addition_points, subtraction_points):
addwords = str(addition_points)
subwords = str(subtraction_points)
await_user_input(addwords)#this can be sued to check the script
await_user_input(subwords)#this can be used to check the script
q=len(addition_points)
if q>0:
for n in range(0,q):
with CompositeAction('Create Sphere ROI (addition)'):

case.PatientModel.RegionsOfInterest['addition'].CreateSphereGeometry(Radius=.25,
Examination=examination, Center={ 'x': addition_points[n][0], 'y': addition_points[n][1], 'z':
addition_points[n][2] })
with CompositeAction('ROI Algebra (Compensator)'):

case.PatientModel.RegionsOfInterest['Compensator'].CreateAlgebraGeometry(Examination=
examination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames':
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior':
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union",
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'SourceRoiNames': ["addition"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior':
0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Union",
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior':
0, 'Right': 0, 'Left': 0 })
gg=len(addition_points)
if gg>0:
for n in range(0,gg):
with CompositeAction('Create Sphere ROI (subtraction)'):

case.PatientModel.RegionsOfInterest['subtraction'].CreateSphereGeometry(Radius=.15,
Examination=examination, Center={ 'x': subtraction_points[n][0], 'y':
subtraction_points[n][1], 'z': subtraction_points[n][2] })
with CompositeAction('ROI Algebra (Compensator)'):

case.PatientModel.RegionsOfInterest['Compensator'].CreateAlgebraGeometry(Examination=
examination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames':
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior':
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union",
'SourceRoiNames': ["subtraction"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0,
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } },
ResultOperation="Subtraction", ResultMarginSettings={ 'Type': "Expand", 'Superior': 0,
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 })
###################
#this script will check the dose at a point, then return with a response of whether the dose is
too high, too low, or normal
def point_dose_check(dose_threshold, mover_position, plan, beam_set, machine_db):
dose_condition=1 #dose condition 1 means the dose is satisfactory, and dose condition 2
means the dose is too hot,dose condition 3 means too cold
check_point = {'x':mover_position[0], 'y':mover_position[1], 'z':mover_position[2]}
check_dose_odd =
plan.TreatmentCourse.TotalDose.InterpolateDoseInPoint(Point=check_point)
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check_dose = math.ceil(check_dose_odd)#this rounds up to the nearest cGy, which just
makes the math simpler
if check_dose >= dose_threshold:
dose_condition = 2
if check_dose <4000:
dose_condition = 3
return dose_condition
###################
#this script will create a list of points that are the starting check points in the xy plane, based
on the gantry angle, isocenter, and applicator size
def start_points_finder(beam_set, dgan_angle):
#first start off creating all the variables I will need
dia = .3
start_points=[]
rgan_angle=dgan_angle*math.pi/180
xshift = dia*math.cos(rgan_angle)
yshift = dia*math.sin(rgan_angle)
app_size = beam_set.Beams['electron beam'].Applicator.DicomApplicatorId
spot = beam_set.Beams['electron beam'].Isocenter.Position
iso_x = spot.x+7*math.sin(rgan_angle)#this moves the starting postition above the
compensator
iso_y = spot.y-7*math.cos(rgan_angle)
iso_z = spot.z
iso_to_edge = 11
startx=iso_x-iso_to_edge*math.cos(rgan_angle)
starty=iso_y-iso_to_edge*math.sin(rgan_angle)
startz=iso_z+iso_to_edge
steps = int(math.floor(2*iso_to_edge/dia))
wordyword = str(steps)
#await_user_input(wordyword) #this can be uncommented to check the step number
#these nested for loops create a list of all the starting check points
for n in range(0, steps):
for k in range(0, steps):
xpoint = startx + k*xshift
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ypoint = starty + k*yshift
zpoint = startz - n*dia
new_point = [xpoint, ypoint, zpoint]
start_points.append(new_point)
#await_user_input('I added a point!') #this can be uncommented just to check its
running
return start_points
###################
#this script finds which starting points actually go into the e_cutout and not compensator
def time_waster_points(mover_point, start_points, start_num1, dgan_angle, case,
examination):
#before we start checking points, we have to see which of the start points we really want to
check. uninteresting start points will be added to the time wasters list
##need to find a better way to exclude these for the comp in air. Probably just check if it
touches the insert within 5 steps and if it does we cut it
time_wasters = []
for n in range(0, start_num1):
mover_point[0] = start_points[n][0]#at the beginning of every start point loop
reinitialize the starting mover position
mover_point[1] = start_points[n][1]
mover_point[2] = start_points[n][2]
counter = 0
check = 3
while (check==3):
comp_pos_check = check_mover2_in_comp(case, plan)
mover_point = move_mover2(mover_point, dgan_angle, case, examination)
counter = counter+1
if counter>15:
check = 1
time_wasters.insert(0, n)#this means this point moved 15 times without
intersecting the compensator, so its not a valuable line to me
##also, by inserting each indice at the beginning of the list I make sure the list is in
decending order, which makes the later indices valid once I start deleting later
if comp_pos_check == 1:
check = 1
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return time_wasters
###################
def mover_point_mover(mover_point, dgan_angle):
#dia is the circle diameter
dia=.3
rgan_angle=dgan_angle*math.pi/180
mover_point[0] = mover_point[0]-.9*dia*math.sin(rgan_angle)
mover_point[1] = mover_point[1] + .9*dia*math.cos(rgan_angle)
return mover_point
###################
#this function will check the dose at the mover point, then return a value that says if it is high
or not
def mover_point_dose_check(mover_point, case, examination):
dose_threshold = 4000
dose_condition = 1#1 means that the doses are all low
check_point = {'x':mover_point[0], 'y':mover_point[1], 'z':mover_point[2]}
check_dose_odd =
plan.TreatmentCourse.TotalDose.InterpolateDoseInPoint(Point=check_point)
check_dose = math.ceil(check_dose_odd)#this rounds up to the nearest cGy, which just
makes the math simpler
if check_dose >= dose_threshold:
dose_condition = 2#this means dose is high
return dose_condition
######################
#this is where the script really starts
#start off by getting the plan info
plan1 = get_current("Plan")
set_check = plan1.GetStructureSet()
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#second, check and see if there already is a compensator ROI in place
try:
comp_check = set_check.RoiGeometries["Compensator"].GetCenterOfRoi()
except:#if there is not a compensator ROI, then initialize it
comp_init() #start it off!
await_user_input("This is the last stop before it takes a (really) long time. Look at the dose
distribution and see if you would like to alter the Compensator shape now. If you change it,
make sure to recalculate dose before proceeding.")
#third, get all the beam and case info
beam_set = get_current("BeamSet")
case=get_current("Case")
examination = get_current("Examination")
plan = get_current("Plan")
machine_db=get_current("MachineDB")
#fourth, set up all the data sets I will need
mover_position = [0,0,0]#start it empty
dgan_angle=beam_set.Beams['electron beam'].GantryAngle#get the gantry angle to start off
with
addition_points=[]#create the list that will store points to be used to cut up the compensator
subtraction_points=[]#create the list that will store points to cut from the compensator
dose_threshold = 4600 #this can be adjusted depending on how sensitive you want the
algorithm to be.
start_points = start_points_finder(beam_set, dgan_angle)#creates a list of origin (x,y,z)
points for the ray lines
start_num1 = len(start_points)
mover_point = [0,0,0]
create_mover(mover_position, case)#here we create the mover and addition rois that we will
fill and use later
time_wasters = time_waster_points(mover_point, start_points, start_num1, dgan_angle, case,
examination)
counter=0#for now this is used to determine the edge of the CTV
check=3#this is the while loop check condition
structure_set=plan.GetStructureSet()
##now we delete all the start points that don't go into the compensator
tw_len = len(time_wasters)
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for n in range(0,tw_len):
start_points.pop(time_wasters[n])
start_num = len(start_points)
#this section can be used to determine if the script is working to take out the wasted points
#words = str(start_num1)
#words2 = str(tw_len)
#words3 = str(start_num)
#await_user_input(words)
#await_user_input(words2)
#await_user_input(words3)
#this for loop is the one that goes and checks all the remaining start points, then adds the
points that need to be modified to a list
for n in range(0, start_num): ##now in these for loops we are checking the points that were
left over that have high doses
counter=0#makes sure we don't go too far from any one start point
check=3#this is the while loop check condition
mover_position[0] = start_points[n][0]#at the beginning of every start point loop
reinitialize the starting mover position
mover_position[1] = start_points[n][1]
mover_position[2] = start_points[n][2]
while (check==3):
mover_position = move_mover(mover_position, dgan_angle, case, examination)#starts
off by moving the move rroi to the next position
counter=counter+1#increase the counter each iteration
if counter>35:#if we have had 25 steps and no interaction with a relevent ROI we call it
quits
check=1
position = check_mover_in_Compensator(case, plan)#now that the ROI is moved, we
see if it is in the ROI we care about
if position == 1: #if it is in the relevent ROI(Compensator), we restart the search and
look for it to leave the CTV
#this takes over at surface of compensator, goes to distal edge of CTV, checks dose,
then adds point to addition points if necessary
current_surface_point = copy.deepcopy(mover_position)
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#await_user_input('We are at the surface of the compensator right here')#can be used
to check the script is working
dose_check_condition = CTV_in_then_out(case, plan, mover_position,
addition_points, beam_set, machine_db, examination, dgan_angle, structure_set)
#lotswords = str(dose_check_condition)#this and the following can be used to check
the script
#await_user_input(lotswords)
if dose_check_condition == 2:
addition_points.append([current_surface_point[0], current_surface_point[1],
current_surface_point[2]])
if dose_check_condition == 3:
subtraction_points.append([current_surface_point[0], current_surface_point[1],
current_surface_point[2]])
counter = 0#and we reset the counter
check = 1#and we end the while loop, which steps us forward in the for loop to our
next start point
#now we modify the compensator based on the points found above
COMP_cutter(case, addition_points, subtraction_points)
#now we smooth out the bumps we created in the compensator
comp_smoother(case, examination)
#after adjusting the compensator, delete mover and addition so they don't interfere with a
subsequent run
with CompositeAction('Delete ROI (mover, addition)'):
case.PatientModel.RegionsOfInterest['mover'].DeleteRoi()
case.PatientModel.RegionsOfInterest['addition'].DeleteRoi()
case.PatientModel.RegionsOfInterest['mover2'].DeleteRoi()
case.PatientModel.RegionsOfInterest['subtraction'].DeleteRoi()
# CompositeAction ends
#and last but not least, dose recalc
beam_set.ComputeDose(ComputeBeamDoses=True,
DoseAlgorithm="ElectronMonteCarlo", ForceRecompute=False)
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